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Abstract
Angiogenesis, the sprouting of new capillaries from existing blood vessels, is essential for the survival of
tissues and normally occurs during development and wound healing. Successful vascularization of
engineered tissues is currently a major challenge, as it is critical for the survival and incorporation of
implanted tissue replacements. While the role of soluble factors in regulating angiogenesis is well
established, there is significant interest in uncovering the contributions of cellular interactions with the
extracellular matrix (ECM). We chose to study the role of cell-ECM adhesion in regulating angiogenesis,
with the hypothesis that quantitative changes in the degree of cell-ECM adhesion can regulate endothelial
cell behaviors important for angiogenesis. We also hypothesized that we could employ our basic
knowledge of angiogenesis to develop a synthetic material system to support vascularization for
potential applications in tissue engineering.
We first examined whether quantitative changes in cell-ECM adhesion regulate angiogenesis and
observed increased angiogenic sprouting in three-dimensional fibrin gels with progressively decreasing
densities of fibrin. Examining changes in global gene expression, we demonstrated a vascular endothelial
growth factor (VEGF)-induced upregulation of genes associated with vascular invasion and remodeling
when cell adhesion was limited, whereas cells on highly adhesive surfaces upregulated genes associated
with proliferation. We showed that proline-rich tyrosine kinase 2 (Pyk2) regulates both gene expression
and endothelial sprouting through its enhanced activation by VEGF in limited adhesion contexts. These
results suggest that limited cell adhesion can enhance endothelial responsiveness to VEGF and
demonstrate a novel role for Pyk2 in the adhesive regulation of angiogenesis.
Finally, we have developed poly(ethylene glycol) (PEG)-based hydrogels that support three-dimensional
angiogenic sprouting. By tuning the mechanical, adhesive, and degradable parameters of these wholly
synthetic materials, we have begun to identify conditions optimal for vascularization, as well as provided
a tool to isolate the effects of single ECM parameters. We have demonstrated control of angiogenic
sprouting by the MMP sensitivity of the hydrogels, as well as an interplay between ECM stiffness and
adhesive ligand density in regulating sprouting.
Together, these studies highlight the importance of cellular interactions with the ECM in regulating
angiogenesis and demonstrate a path by which we can apply basic understanding toward vascularization
of engineered tissues for tissue regeneration and repair.
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ABSTRACT
REGULATION OF ANGIOGENESIS BY ADHESIVE AND MECHANICAL CUES
FROM THE EXTRACELLULAR MATRIX
Colette Shen
Supervisor: Christopher Chen

Angiogenesis, the sprouting of new capillaries from existing blood vessels, is
essential for the survival of tissues and normally occurs during development and wound
healing. Successful vascularization of engineered tissues is currently a major challenge,
as it is critical for the survival and incorporation of implanted tissue replacements. While
the role of soluble factors in regulating angiogenesis is well established, there is
significant interest in uncovering the contributions of cellular interactions with the
extracellular matrix (ECM).

We chose to study the role of cell-ECM adhesion in

regulating angiogenesis, with the hypothesis that quantitative changes in the degree of
cell-ECM adhesion can regulate endothelial cell behaviors important for angiogenesis.
We also hypothesized that we could employ our basic knowledge of angiogenesis to
develop a synthetic material system to support vascularization for potential applications
in tissue engineering.
We first examined whether quantitative changes in cell-ECM adhesion regulate
angiogenesis and observed increased angiogenic sprouting in three-dimensional fibrin
gels with progressively decreasing densities of fibrin. Examining changes in global gene
expression, we demonstrated a vascular endothelial growth factor (VEGF)-induced
upregulation of genes associated with vascular invasion and remodeling when cell
iii

adhesion was limited, whereas cells on highly adhesive surfaces upregulated genes
associated with proliferation. We showed that proline-rich tyrosine kinase 2 (Pyk2)
regulates both gene expression and endothelial sprouting through its enhanced activation
by VEGF in limited adhesion contexts. These results suggest that limited cell adhesion
can enhance endothelial responsiveness to VEGF and demonstrate a novel role for Pyk2
in the adhesive regulation of angiogenesis.
Finally, we have developed poly(ethylene glycol) (PEG)-based hydrogels that
support three-dimensional angiogenic sprouting. By tuning the mechanical, adhesive,
and degradable parameters of these wholly synthetic materials, we have begun to identify
conditions optimal for vascularization, as well as provided a tool to isolate the effects of
single ECM parameters. We have demonstrated control of angiogenic sprouting by the
MMP sensitivity of the hydrogels, as well as an interplay between ECM stiffness and
adhesive ligand density in regulating sprouting.
Together, these studies highlight the importance of cellular interactions with the
ECM in regulating angiogenesis and demonstrate a path by which we can apply basic
understanding toward vascularization of engineered tissues for tissue regeneration and
repair.
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CHAPTER 1
INTRODUCTION/BACKGROUND

1.1 Rationale and Hypotheses
Angiogenesis is a critical regulator of tissue function in both healthy and diseased
states: vascularization of normal tissues provides essential oxygen and nutrients during
development and wound healing, while dysregulated angiogenesis associated with
diseases such as cancer and diabetic retinopathy further contributes to disease
progression. Understanding how angiogenesis is regulated by the microenvironment,
then, is crucial for maintaining the survival and health of implanted tissues for
regenerative medicine, as well as identifying ways to curb angiogenesis as one avenue to
treat cancers and diabetic retinopathy. The general goal of this thesis is to elucidate
further how cellular interactions with the ECM regulate angiogenesis and to apply this
knowledge toward engineering materials that promote vascularization.

A major

hypothesis is that changes in the degree of cell adhesion to the ECM regulate distinct
endothelial cell behaviors important for angiogenesis. We also hypothesize that by
controlling

various

ECM

parameters—including
1

adhesive

ligand

presentation,

mechanical stiffness, and degradability—in a synthetic material system, we can control
the extent of vascularization to enable efforts in tissue engineering. The remainder of this
chapter provides background on what is currently known about ECM regulation of
angiogenesis, as well as existing engineered materials used to study tissue
vascularization.

1.2 Clinical Relevance
Cardiovascular disease is the leading cause of death and disability in the U.S. and
most Western countries. This mostly is due to the narrowing and eventual blockage of
blood vessels to the normal flow of blood, causing tissue ischemia and damage. As such,
therapeutic interventions to treat cardiovascular disease include strategies to revascularize
these ischemic tissues. Among the two most common surgical procedures for coronary
or peripheral vascular disease are the placement of stents (to re-open narrowing vessels
physically) or introduction of a bypass graft to circumvent diseased vessels. While such
approaches have proven to be widely successful in cases where vascular disease is
restricted to large vessels, in many settings the limitation for blood flow is in the
microvasculature. In this setting, it is clear that the most promising approach is to
promote the formation of additional microvessels in the ischemic tissue. In addition to
what is now referred to as “therapeutic angiogenesis,” our ability to promote controlled
neovascularization is also critical to the success of tissue engineering as a strategy for
organ replacement. Currently, investigators have demonstrated a number of promising
avenues to engineer cells and biomaterials to form tissue-like structures in culture. Our
ability to translate these in vitro tissues into transplantable replacement tissues is now
2

limited by our ability to promote the successful vascularization of the engineered
constructs. As most cells must reside within 200μm of the nearest capillary for proper
gas exchange, nutrient delivery, and waste removal (Jain, 1999; Jain et al., 2005), a
failure to vascularize an engineered implant would either result in massive failure of the
implant or limit us to implant only tiny structures.
Historically, the strategies for promoting angiogenesis in these clinical settings
have focused largely on gene- and cell-based therapies for delivering angiogenic
cytokines and progenitor cells to promote neovascularization (Renault and Losordo,
2007). Studies of the fundamental process of angiogenesis over the past decade have
revealed that in addition to the appropriate cells and soluble factors, the extracellular
matrix (ECM) environment is also a critical regulator that can either promote or prevent
neovascularization of a tissue.

1.3 Regulation of angiogenesis by the microenvironment
Angiogenesis is the sprouting of new capillaries from existing vessels and
involves the activation of quiescent endothelium to degrade the surrounding ECM,
proliferate and migrate away from existing vessels, and assemble to form hollow,
elongated, branching tubes (Adams and Alitalo, 2007).

Angiogenesis requires the

cooperative signaling of both soluble growth factor and matrix-mediated adhesive and
mechanical cues (Fig. 1.1). Several growth factors are known to regulate various aspects
of angiogenesis, among them vascular endothelial growth factor (VEGF), basic fibroblast
growth factor (bFGF), placental growth factor (PlGF), and platelet-derived growth factor
(PDGF). Studies of angiogenesis in tumors have revealed that inhibition of VEGF,
3

bFGF, PDGF, and, more recently, PlGF signaling blocks angiogenesis (Drevs et al.,
2002; Ferrara, 2004; Levin et al., 2004). Clinically, these inhibitors potently inhibit
angiogenesis in certain cancers and in diabetic retinopathy (Cabebe and Fisher, 2007;
Ferrara, 2004; Goodman, 2004; Hanrahan and Heymach, 2007; Hilberg et al., 2008;
Manegold, 2008; Simo and Hernandez, 2008). Likewise, agents that block endothelial
cell adhesion to ECM profoundly inhibit angiogenesis in animal studies, and these
approaches are being assessed as potential clinical cancer treatments (Drake et al., 1995;
Gutheil et al., 2000; Hood et al., 2002; Trikha et al., 2004).

Figure 1.1. Microenvironmental regulation of angiogenesis. The various steps of
angiogenesis (basement membrane degradation, proliferation and migration away from
an existing vessel, and capillary morphogenesis) are regulated by soluble growth factors
and cellular interactions with the extracellular matrix. Adapted from (Ingber, 2002).
4

1.4 Regulation of angiogenesis by cell adhesion to extracellular matrix
While the mechanisms by which soluble factors promote angiogenesis are
relatively straightforward, how cell adhesion to the ECM modulates endothelial cell
behavior requires a more careful examination of the literature. Cell adhesion involves
binding of integrins to ECM ligands, as well as cell spreading against the substrate and
subsequent generation of cytoskeletal tension.

Each of these different aspects of

adhesion (integrin binding, changes in cell shape, and alterations in cytoskeletal
mechanics) appears to impact endothelial cell function.
The importance of integrin-mediated adhesion in angiogenesis has been well
established: antagonists of αvβ3, αvβ5, α5β1, α1β1, and α2β1 have been shown to inhibit
endothelial cell adhesion and migration in vitro and angiogenesis in vivo using the chick
chorioallantoic membrane (CAM) model (Fig. 1.2A) or vascularization of human skin
transplanted onto SCID mice (Brooks et al., 1994a; Friedlander et al., 1995; Kim et al.,
2000; Senger et al., 1997). Interestingly, these integrins are not highly expressed on
quiescent endothelium but are upregulated in tumors, wounds, and sites of inflammation
and in response to angiogenic growth factors (Avraamides et al., 2008). These integrins
appear to regulate diverse angiogenic pathways, as blocking engagement of αvβ3 and
α5β1 integrins inhibits basic fibroblast growth factor (bFGF)-induced angiogenesis, while
blocking αvβ5, α1β1, and α2β1 engagement inhibits VEGF-induced angiogenesis.
Integrin knockout studies, on the other hand, suggest certain integrins—αv, β3, β5, α1,
and α2—are not always necessary for vascular development (Bader et al., 1998;
Hodivala-Dilke et al., 1999; Huang et al., 2000; Pozzi et al., 2000; Zhang et al., 2008).

5

Figure 1.2.

Cell adhesion to the ECM regulates angiogenesis.

(A) Tumor

angiogenesis on the chick chorioallantoic membrane (CAM) is inhibited by cyclic RGD
peptide, which antagonizes integrin αvβ3 binding to the ECM. From (Brooks et al.,
1994b). (B) The degree of cell spreading, controlled by varying sizes of micropatterned
islands of fibronectin, regulates endothelial cell proliferation versus apoptosis, with
greater proliferation in more highly spread cells. From (Chen et al., 1997). (C) Low
concentrations of the αvβ3/αvβ5 inhibitors S 36578 and cilengitide promote VEGFmediated angiogenesis from mouse aortic rings, compromising anti-angiogenic effects.
From (Reynolds et al., 2009).
6

These discrepancies can be explained in part by compensatory upregulation of other
angiogenesis signaling pathways, such as VEGF receptor 2 signaling in β3-null mice
(Reynolds et al., 2004) and VEGF receptor 1 signaling in α2-null mice (Zhang et al.,
2008), though these studies still leave many questions unanswered.
The molecular intermediaries by which integrin engagement impacts endothelial
cell behavior are largely found in focal adhesions. Binding and clustering of integrins to
specific ECM ligands leads to the recruitment of numerous scaffolding and signaling
proteins to the site of integrin ligation, forming these dynamic structures known as focal
adhesions (Burridge et al., 1988; Miyamoto et al., 1995; Plopper et al., 1995). Signaling
proteins (e.g., FAK, Src, ERK, RhoA) that are regulated by integrin activation also
function in growth factor signaling, suggesting that focal adhesions act to coordinate
integrin and growth factor signaling (Schwartz, 1997; Stupack and Cheresh, 2004).
Indeed, growth factor receptors are concentrated within sites of focal adhesion formation
(Plopper et al., 1995), and different integrins within focal adhesions interact with specific
growth factor receptors (Mettouchi et al., 2001; Schneller et al., 1997). For example,
VEGF and bFGF signal synergistically with integrins αvβ5 and αvβ3, respectively, to
activate the Ras-Erk pathway to modulate angiogenesis (Hood et al., 2003). Focal
adhesion kinase (FAK), a key signaling protein localized to focal adhesions, is known to
transduce both soluble growth factor and integrin adhesion signals to regulate cell
proliferation, migration, and survival (Parsons, 2003; Pirone et al., 2006; Schober et al.,
2007; Vadali et al., 2007). Importantly, FAK is essential for vascular development in
vivo as demonstrated by the embryonic lethality of endothelial-specific FAK knockout in
mice (Braren et al., 2006; Shen et al., 2005). Further downstream, sustained ERK
7

activity in response to growth factor and integrin-mediated adhesive cues is required for
angiogenesis in vivo (Eliceiri et al., 1998). Such studies provide a molecular context for
how cell adhesion can modulate growth factor-mediated responses and emphasize the
importance of integrin-mediated adhesion in transducing signals from the ECM.
While these studies clearly demonstrate the importance of integrin-mediated
adhesion in regulating angiogenesis, several studies also suggest that the degree of cell
adhesion and spreading can strongly impact endothelial cell behavior. Varying cell
spreading by changing the density of the ECM protein, fibronectin, immobilized on
culture surfaces results in increased proliferation at high densities and quiescence at low
densities (Ingber, 1990; Ingber and Folkman, 1989).

The use of micropatterned

substrates with defined adhesive and surrounding non-adhesive regions extended these
findings further. Such substrates dictate the area of cell-ECM contact and allow for more
precise control of cell adhesion and shape (Singhvi et al., 1994).

Controlling cell

spreading by culturing cells on different sizes of adhesive islands showed greater
proliferation in endothelial cells cultured on large adhesive islands and an increase in
apoptosis on small adhesive islands (Fig. 1.2B) (Chen et al., 1997).

Interestingly,

between these two extremes of high and low spreading, studies have shown enhanced
cell-cell interaction and tubulogenesis at intermediate levels of adhesion. Intermediate
cell-ECM adhesion, achieved either by introducing antibodies that block integrin binding
or by coating substrates with intermediate amounts of ECM protein, resulted in increased
tubulogenesis, decreased spreading, and decreased proliferation in vitro (Gamble et al.,
1993; Ingber and Folkman, 1989). Similarly, confining endothelial cells on patterned
adhesive lines of intermediate width promoted morphogenesis of cells into tubules with
8

lumens (Dike et al., 1999). A recent study also demonstrated an unexpected increase in
tumor angiogenesis in vivo in response to low concentrations of RGD-mimetic integrin
inhibitors, under development as anti-angiogenic cancer therapeutics (Fig. 1.2C)
(Reynolds et al., 2009). A biphasic response was observed, such that no inhibitor had
minimal effect on angiogenesis, high concentrations of inhibitor decreased angiogenesis,
but intermediate concentrations actually increased angiogenesis above baseline levels.
These studies all point to the possibility of enhanced capillary differentiation and
angiogenesis at intermediate levels of adhesion (Fig. 1.3).

Figure 1.3. Endothelial cell behavior is regulated by adhesion. Changes in the degree
of cell-ECM adhesion result in a switch between apoptosis, tubulogenesis, and
proliferation.

Given the dynamic nature of cell invasion and sprouting during angiogenesis, the
adhesive interaction between endothelial cells and the ECM is constantly changing.
Matrix degradation leads to release of ECM fragments and exposure of cryptic binding
sites, and new matrix deposition provides additional ECM ligands for integrin ligation.
Specifically, denatured collagen is found around angiogenic, but not quiescent, vessels
9

(Brooks et al., 1996), and collagen type IV cleavage reveals cryptic binding sites that
interact preferentially with αvβ3 integrins upregulated in angiogenic vessels over α1β1
integrins (Xu et al., 2001). The importance of adhesive interactions with these cryptic
sites is evidenced by the inhibition of angiogenesis in vivo with antibodies directed
against these sites. Proteolytic activity also results in release of fragments of ECM
proteins and proteases, all of which can ligate integrins and have been shown to block
angiogenesis by altering integrin interactions with the ECM. These include endostatin, a
fragment of collagen XVIII (O'Reilly et al., 1997); tumstatin, a fragment of collagen IV
(Maeshima et al., 2000); angiostatin, a fragment of plasminogen (O'Reilly et al., 1994);
and PEX, a fragment of matrix metalloproteinase 2 (MMP-2) (Brooks et al., 1998).
Finally, new matrix deposition—either from the plasma as a result of increased
endothelial permeability or directly produced by endothelial and supporting
mesenchymal cells—provides additional ligands for adhesion. Fibronectin, vitronectin,
and fibrinogen are among the provisional matrix proteins deposited from the plasma, and
tenascin and thrombospondins are provisional ECM proteins produced by endothelial
cells (Davis and Senger, 2005; Stupack and Cheresh, 2004).

Returning full circle,

endothelial-pericyte interactions appear to enhance production of basement membrane
proteins such as laminins, collagen IV, and nidogens to stabilize newly formed vessels
(Stratman et al., 2009a). These examples underscore not only the importance of the
adhesive interactions between endothelial cells and the ECM in modulating angiogenesis,
but also the complex dynamic nature of the entire process.

10
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Figure 1.4. Cell contractility and ECM mechanical properties regulate angiogenesis.
(A) Increased cell spreading increases cell contractility, as measured by culture on arrays
of flexible micro-posts. From (Tan et al., 2003). (B) RhoA manipulations regulate
VEGF-driven angiogenesis in mouse skin. From (Hoang et al., 2004). (C) Fibrin density
regulates endothelial cell sprouting from microcarrier beads, with higher densities
inhibiting sprouting. From (Ghajar et al., 2008a). (D) Intermediate stiffness of Matrigel
promotes angiogenesis in vivo as measured by cellular infiltration and VEGFR2
expression. From (Mammoto et al., 2009).
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1.5 Mechanical regulation of angiogenesis
As cells attach and spread against an ECM substrate, RhoA and its effector
ROCK are activated, leading to actin-myosin-generated contractility and further
maturation of focal adhesions (Amano et al., 1996; Chrzanowska-Wodnicka and
Burridge, 1996; Ishizaki et al., 1996; Kimura et al., 1996). Studies from our group and
others have demonstrated that progressively increasing cell spreading activates RhoAROCK- and myosin-mediated cytoskeletal tension, along with enhanced assembly of
robust stress fibers and focal adhesions (Bhadriraju et al., 2007; Chen et al., 2003;
McBeath et al., 2004; Pirone et al., 2006; Polte et al., 2004; Ren et al., 2004). Using a
microfabricated device containing arrays of microneedles that directly reports traction
forces (Tan et al., 2003), we demonstrated that the degree of cell spreading regulates the
magnitude of cytoskeletal tension generated by cells cultured on the posts (Fig. 1.4A).
Together, these studies demonstrate a tight link between cellular mechanics and cell
adhesion.
Importantly, these changes in cell contractility appear to be critical in modulating
endothelial cell function. For example, RhoA-ROCK-mediated contractility is key in
regulating proliferation (Pirone et al., 2006), and Ingber and colleagues have shown that
cell spreading-mediated changes in RhoA signaling regulate the G1/S transition in cell
cycle progression by increasing expression of the transcriptional regulator Skp2 (Huang
et al., 1998; Mammoto et al., 2004). RhoA-ROCK-mediated contractility has also been
shown to be important for endothelial cell migration and capillary morphogenesis in vitro
and angiogenesis in vivo (Fig. 1.4B) (Bryan and D'Amore, 2007; Hoang et al., 2004; Liu
and Senger, 2004; Uchida et al., 2000; van Nieuw Amerongen et al., 2003), and directly
13

inhibiting myosin signaling or disrupting the actin cytoskeleton decreases capillary
sprouting and endothelial cell proliferation (Huang et al., 1998; Kniazeva and Putnam,
2009).
Given that ECM stiffness has been reported to increase cellular contractility,
might the mechanical properties of the ECM also regulate angiogenesis via alteration of
cell-generated tension against the ECM? Increases in matrix stiffness have been shown
in other cell types to activate FAK, RhoA-ROCK, and myosin activity (Engler et al.,
2006; Paszek et al., 2005; Wozniak et al., 2003). Furthermore, the combination of
increased contractility and increased rigidity of the substrate against which cells pull
leads to higher stresses generated between the cell and substrate. Studies suggest that it is
the tension generated when cells pull against a rigid substrate, rather than contractile
activity within cells themselves, that drives cell function. In the absence of adhesion to a
rigid substrate, activation of RhoA cannot generate cytoskeletal tension and fails to
support focal adhesion formation or proliferative signaling (Assoian and Schwartz, 2001;
Bhadriraju et al., 2007; Ren et al., 1999; Ren et al., 2004; Renshaw et al., 1996).
Early studies demonstrated changes in endothelial cell behavior when grown on
malleable substrates versus on traditional rigid tissue culture surfaces—for example, the
arrangement of endothelial cells into capillary tubes on soft gels and into monolayers on
rigid surfaces (Montesano et al., 1983; Schor et al., 1983)—and have suggested the
possibility that mechanical cues from the ECM indeed play an important role in
regulating endothelial cell behavior. However, only recently have the tools to study the
role of matrix elasticity in angiogenesis well become available.

Primarily in other

biological contexts, matrix stiffness has been shown to regulate numerous cellular
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behaviors, including adhesion, contractility, spreading, motility, proliferation, and
differentiation (Discher et al., 2005; Engler et al., 2006; Paszek et al., 2005; Pelham and
Wang, 1997; Peyton et al., 2006; Wang et al., 2000; Wozniak et al., 2003; Yeung et al.,
2005). In studies with endothelial cells, it has been shown using natural ECMs such as
fibrin and Matrigel that lower density and thus more compliant matrices tend to support
capillary morphogenesis, while denser and thus more rigid matrices promote endothelial
proliferation and migration (Fig. 1.4C) (Ghajar et al., 2006; Nehls and Herrmann, 1996;
Sieminski et al., 2004; Vailhe et al., 1997). Matrix compliance is but one of many
properties varied in these ECMs, however, and endothelial cell responses have been
attributed to limitations in diffusion and changes in MMP production in addition to
compliance (Ghajar et al., 2006; Ghajar et al., 2008a). To address this shortcoming,
others have varied the stiffness of collagen gels by using glycation-induced crosslinking,
while holding collagen density constant. Consistent with studies varying ECM density,
increased ECM stiffness suppresses tubulogenesis while increasing proliferation (Kuzuya
et al., 1998). Because crosslinking of the matrix itself can locally alter ligand density,
hydration state, flexibility, or conformation (thereby affecting cell adhesion through
changes in integrin binding rather than by mechanical effects), investigators have
developed non-adhesive hydrogels, such as polyacrylamide or poly(ethylene glycol)
(PEG), where crosslinking occurs on the non-adhesive backbone, and the ECM ligand is
covalently attached in a separate chemical step to decouple ECM ligand density from
stiffness manipulations (Mann et al., 2001a; Pelham and Wang, 1997). Gelatin-coupled
polyacrylamide gels of different stiffness exhibit enhanced tubulogenesis on more
compliant matrices (Deroanne et al., 2001). In addition, a recent study demonstrated
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enhanced angiogenesis at an intermediate stiffness of Matrigel in vivo (where stiffness
was controlled by transglutaminase-mediated protein crosslinking) (Fig. 1.4D) and
showed that related endothelial cell responses are similarly biphasic on 2-dimensional
polyacrylamide gels of varying stiffness (Mammoto et al., 2009).
Although these studies are beginning to uncover a role for matrix mechanics in
angiogenesis, it should be cautioned that mechanical properties of tissues could be
dynamically changing over time due to degradation by cellular proteases and deposition
of new matrix proteins, so studies of matrix stiffness currently can only accurately report
effects of initial mechanical properties. In angiogenesis, membrane type 1 MMP (MT1MMP, or MMP14) has been shown to be particularly important and is highly expressed at
the tips of angiogenic sprouts (Chun et al., 2004; Collen et al., 2003; Ghajar et al., 2006;
Hiraoka et al., 1998; Lafleur et al., 2002; Stratman et al., 2009b; Yana et al., 2007). It is
possible, then, that a certain local mechanical compliance—different from initial
conditions—must be reached before sprout invasion into a matrix can occur. However,
the rate of sprouting into matrices of different initial stiffness should vary, as may the
character of sprouting given the differences in angiogenesis in stiffer tumor tissues versus
softer healthy tissues. Mechanical gradients along sprouts resulting from differential
matrix degradation and deposition also point to the importance of studying relative
differences in mechanical properties on angiogenesis, even if initial conditions are not
maintained.

Finally, studies have suggested that increased mechanical stiffness can

increase matrix deposition (Khatiwala et al., 2006; Li et al., 2007), resulting in a positive
feedback loop that could significantly impact the dynamic properties of the ECM
surrounding angiogenic vessels.
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It can be appreciated from these studies that not only the extent but also the
quality or character of angiogenesis could potentially be controlled simply by changing
the adhesive or mechanical properties of the ECM. Shifts in cellular responses to these
manipulations from proliferation to capillary morphogenesis and apoptosis, all in the
presence of similar soluble factor conditions, could alter the overall architecture of
vascular networks as they form. Such a perspective could potentially help explain why
certain cells in an angiogenic sprout proliferate while others undergo capillary
morphogenesis, as well as why pathological angiogenesis varies so much in character
from normal angiogenesis. The similar trends in angiogenic responses to changes in the
amount of integrin-mediated adhesion, cell spreading, and matrix compliance suggest that
perhaps similar downstream signaling pathways are responding to control cellular
responses.

Importantly, we can also use these findings to inform our efforts to

vascularize engineered tissues for tissue regeneration using rationally designed materials.

1.6 Engineered materials to promote vascularization
Given current understanding of how adhesive and mechanical properties of the
ECM regulate angiogenesis, a major goal is to employ this knowledge toward
engineering materials to promote optimal vascularization for tissue engineering and
therapeutic angiogenesis. While most current strategies focus on soluble factor delivery
to induce neovascularization of ischemic tissue or material implants, it is clear that proper
signals from the ECM are also required for optimal tissue vascularization. Soluble
angiogenic factors, such as VEGF and bFGF, delivered by either controlled-release
scaffolds or transfected cells, cannot attract native microvessels into the implanted
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construct without the appropriate adhesive cues from the ECM (Hall, 2007; LeslieBarbick et al., 2009; Lutolf and Hubbell, 2005; Zisch et al., 2003). Conversely, ECMs
designed specifically to promote vascularization of implanted tissues require soluble
growth factors for efficient angiogenesis (Cai et al., 2005; Perets et al., 2003; Smith et al.,
2004; Tanihara et al., 2001; Yoon et al., 2006), highlighting the importance of both
soluble and matrix cues in engineered systems for angiogenesis.
In engineering materials for angiogenesis, we can use principles guided by our
studies of angiogenesis in natural ECMs. In vivo, sprouting angiogenic vessels first
degrade and migrate through laminin- and collagen IV-rich basement membrane that
surrounds quiescent vessels, then extend into an interstitial matrix containing collagen I
and provisionally deposited fibrin and fibronectin matrices (Carmeliet, 2003). Many
studies of tissue implant vascularization, as well as in vitro systems to investigate the
mechanisms and processes involved in angiogenesis, use these natural ECMs. They
provide the adhesive, mechanical, and degradable properties known to promote robust
vascularization in tissues in vivo, as well as the ability to tether and retain soluble growth
factors via heparin binding sites (Ramirez and Rifkin, 2003), another important signal for
vessel ingrowth. In a key study in efforts to engineer functional, stable vessels, Jain and
colleagues implanted type I collagen scaffolds containing endothelial and mesenchymal
precursor cells in mice and reported the assembly of vascular networks that anastomosed
with the host vasculature and remained stable for several months (Fig. 1.5A) (Koike et
al., 2004). Similar results were reported with the implantation of endothelial progenitor
cells and smooth muscle cells in laminin-rich Matrigel (Melero-Martin et al., 2007) and
pre-formed endothelial cell spheroids in a fibrin-Matrigel matrix (Alajati et al., 2008).
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Figure 1.5. Engineering materials to promote tissue vascularization. (A) Endothelial
cells and pericytes co-seeded in collagen gel implants begin to form vascular networks at
4 days (left) and are stable and fully perfused at 4 months (right). From (Koike et al.,
2004). (B) One synthetic scheme used to create biomimetic PEG materials. Monocysteine adhesive peptides and bis-cysteine MMP-sensitive peptides are coupled to
multiarm PEGs via Michael-type addition reaction to allow cell migration through the
matrix. From (Lutolf et al., 2003b).
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Several others have employed in vitro assays of capillary sprouting or morphogenesis in
fibrin and type I collagen matrices to uncover the contribution of supporting
mesenchymal cells and MMPs in these processes, as well as the signaling mechanisms
regulating vessel invasion and lumen formation (Bayless and Davis, 2002; Bayless and
Davis, 2003; Ghajar et al., 2006; Griffith et al., 2005; Koh et al., 2008; Nakatsu et al.,
2003; Sainson et al., 2005; Saunders et al., 2006; Stratman et al., 2009b). As noted
above, the adhesive and mechanical properties of these natural ECMs can be altered to
some extent by varying matrix density, resulting in variations in angiogenic behavior;
however, changes in density are accompanied by changes in adhesive ligand
concentration, mechanical stiffness, degradability, and porosity, so the exact contribution
of each parameter to angiogenic responses cannot easily be determined.
Because of such limitations, despite the availability and known vascularization
potential of natural ECMs, investigators continue to create increasingly synthetic systems
in attempts to control more precisely material parameters such as compliance, adhesive
ligand density and type, and porosity (Lutolf and Hubbell, 2005). Synthetic materials
also allow for covalent incorporation of known pro-angiogenic factors such as soluble
growth factors and cell-cell guidance molecules, as well as pre-patterning of regions
within a material to control vascularization spatially. Some natural ECMs have been
“engineered” to incorporate additional functionalities to enhance vascularization. For
instance, increased growth factor retention in fibrin and collagen matrices has been
achieved through covalent coupling of VEGF itself (Ishikawa et al., 2006; Koch et al.,
2006; Zisch et al., 2001), heparin-binding peptides or heparin itself that promote binding
of heparin-bound growth factors such as VEGF and bFGF (Pieper et al., 2002; Sakiyama20

Elbert and Hubbell, 2000; Steffens et al., 2004), and collagen-mimetic peptides that
attract growth factors to collagen gels via charge-charge interactions (Wang et al., 2008).
Natural ECMs can also be chemically crosslinked to alter compliance independent of
adhesive ligand density (Kuzuya et al., 1998; Standeven et al., 2007).
Because many of these natural ECMs are derived from animal tissues and so
present the potential risk of immunogenicity and infectious pathogens (Brown and
Phillips, 2007; Lutolf and Hubbell, 2005), fully synthetic material systems are ultimately
preferred for purposes of generating vascularized tissue constructs for implantation. Two
primary material backbones, non-toxic and approved for in vivo clinical applications,
have been used for this purpose: porous scaffolds formed from poly(lactic-co-glycolic
acid) (PLGA) and PEG hydrogels functionalized with oligopeptides rendering them cell
adhesive and degradable.

Both materials satisfy the requirements of complete

degradation and resorption in vivo after serving as temporary mechanical supports for
cell ingrowth. PLGA scaffolds have long been used in medical implants such as sutures
and prosthetic devices due to their biocompatibility and biodegradability (Athanasiou et
al., 1996; Gunatillake and Adhikari, 2003). Their mechanical and degradation properties
can be altered by varying the ratio of lactic and glycolic acids. PLGA itself is not cell
adhesive, but when implanted it nonspecifically adsorbs proteins from fluids in the body,
rendering implanted PLGA scaffolds cell adhesive (Miller et al., 2005; Tjia et al., 1999).
Mooney and colleagues have demonstrated vascular ingrowth in PLGA scaffolds
containing VEGF alone (Peters et al., 2002; Sheridan et al., 2000) and VEGF with PDGF
(Richardson et al., 2001), with the addition of PDGF promoting the formation of mature,
stable vessels supported by smooth muscle cells. Langer and colleagues prevascularized
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skeletal muscle constructs before implantation by co-seeding endothelial cells, myoblasts,
and embryonic fibroblasts on scaffolds composed of PLGA and poly(L-lactic acid)
(PLLA) (Levenberg et al., 2005). They demonstrated that pre-formed vascular networks
indeed improved the viability and vascularization of the skeletal muscle constructs after
implantation.
While PLGA scaffolds have proven capable of supporting vascularization in
implanted constructs, PEG hydrogels possess significant advantages over other material
systems as biomimetic, tunable scaffolds for engineered tissue vascularization. Since
natural ECMs themselves are hydrogels (Lutolf and Hubbell, 2005), the basic structure of
PEG hydrogels is ideal for serving as a native tissue replacement. Crosslinked polymers,
like natural ECM protein fibrils, resist tensile stresses, while interstitial fluid resists
compressive stresses.

Given the importance of matrix rigidity in angiogenesis, the

mechanical tunability of PEG, by varying either its crosslinking density or chain length
between crosslinks, is significant. The rigidity of PEG can be varied widely, with
reported Young’s modulus values between 300Pa-100kPa (Elbert and Hubbell, 2001;
Lutolf and Hubbell, 2003; Raeber et al., 2005), spanning a significant range of biological
tissues. While PEG itself is not adhesive to proteins or cells (Gombotz et al., 1991),
oligopeptides representing key integrin binding regions within native ECM adhesion
proteins such as fibronectin or laminin can be covalently crosslinked to the PEG network
(Hern and Hubbell, 1998), such that cells adhere to the PEG matrix only through those
specific adhesive peptides, while the remaining polymer network is relatively inert. The
most common adhesive ligand incorporated is the ubiquitous RGD ligand (Hersel et al.,
2003), found in fibronectin, vitronectin, fibrinogen, and several other ECM adhesion
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proteins (Ruoslahti and Pierschbacher, 1987), but other adhesive sequences such as
IKVAV (from laminin) or REDV (from the fibronectin IIICS region) have also been
incorporated so that the adhesive ligand can be tailored to the cell type of interest (Shin et
al., 2003).

This synthetic scheme allows for variations of adhesive ligand density

independent of other parameters such as stiffness and porosity, permitting investigation
of the contributions of these material parameters to cell behavior independently. For
instance, independent variation of adhesive ligand density has demonstrated a biphasic
effect of ligand density on cell migration in 3-dimensional matrices (Burgess et al., 2000;
Gobin and West, 2002; Lutolf et al., 2003a; Schense and Hubbell, 2000) and may provide
one explanation for the enhanced angiogenesis observed at intermediate degrees of
adhesion (Ingber and Folkman, 1989; Reynolds et al., 2009).
The ability to incorporate oligopeptides into a PEG backbone endows it with not
only a cell adhesive property but also several other biological functionalities
characteristic of natural ECMs.

Proteolytically degradable sequences allow cells to

degrade and migrate through the material via cell-secreted proteases, as the nanometerscale pores in PEG hydrogels do not normally permit invasion and migration (Lutolf et
al., 2003a; Lutolf et al., 2003b; Mann et al., 2001a). These sequences can be tailored to
be sensitive to various proteases, including MMPs and plasmin, and thus specific to the
biological process being studied. Similar to the “engineered” natural ECMs described
earlier, growth factors can be incorporated into PEG hydrogels either directly or through
binding to heparin (Benoit et al., 2007; Gobin and West, 2003; Mann et al., 2001b; Zisch
et al., 2003). The chemistry to polymerize and incorporate biological functionalities into
PEG materials is now sufficiently well established and compatible with living cells and
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tissues such that the material can even be polymerized in situ after encapsulation of cells.
West and colleagues have utilized a scheme in which acrylated PEG derivatives are
photopolymerized with proteolytically degradable and cell adhesive oligopeptides such
that degradable sequences are incorporated in the PEG backbone, and adhesive sequences
are attached as pendant chains (Gobin and West, 2002; Mann et al., 2001a; West and
Hubbell, 1999). Hubbell and colleagues employ Michael-type crosslinking reactions
between end-functionalized PEG macromers and thiol-bearing compounds (such as the
amino acid cysteine) to form similar degradable and adhesive matrices (Fig. 1.5B) (Elbert
and Hubbell, 2001; Lutolf et al., 2003a; Lutolf et al., 2003b). Recently, Anseth and
colleagues have developed chemistries involving thiol-ene photopolymerization (Aimetti
et al., 2009) and sequential click reactions to pattern 3D PEG hydrogels (DeForest et al.,
2009). The end result is a biocompatible, biomimetic material that can be customed
tailored for the biological process or tissue type being studied via modular incorporation
of bioactive oligopeptides.
In the context of angiogenesis, the potential for PEG hydrogels to serve as
scaffolds for vascularization has only begun to be realized. Hubbell and colleagues
demonstrated enhanced angiogenesis in response to VEGF covalently bound to and then
released from PEG scaffolds by cell-mediated proteolytic degradation (Zisch et al.,
2003). Vascularization on the chick CAM was improved with covalently bound VEGF
over soluble VEGF, and scaffolds implanted subcutaneously in rats were replaced by
vascularized tissue. West and colleagues have added several functionalities to PEG to
improve endothelial cell function:

covalent immobilization of VEGF enhanced

endothelial cell tubulogenesis on the surface of PEG hydrogels and migration and cell24

cell interaction of cells encapsulated within degradable hydrogels (Leslie-Barbick et al.,
2009).

Endothelial cell adhesion and tubule formation were promoted by covalent

incorporation of ephrin A1, a cell-cell adhesion molecule important in regulating vascular
guidance and assembly (Moon et al., 2007). By patterning lines of RGDS on the surface
of PEG hydrogels, they demonstrated formation of endothelial cords only on lines of
intermediate width, and only at intermediate RGDS concentrations (Moon et al., 2009),
consistent with previous results demonstrating enhanced tubulogenesis at intermediate
densities of fibronectin and on fibronectin lines of intermediate width (Dike et al., 1999;
Ingber and Folkman, 1989). Further techniques developed to pattern PEG hydrogels in
2D and 3D (Hahn et al., 2006a; Hahn et al., 2006b) can potentially be used to control
spatially the adhesive, mechanical, and degradable properties of the matrix to generate
complex vascularized tissues. Taking further advantage of the mechanical, adhesive, and
degradable tunability of PEG will provide further insight into ECM regulation of
angiogenesis and aid in the rational design of materials for tissue repair.

1.7 Multicellular interactions in angiogenesis
In vivo, vascular cells exist in multicellular tubular structures and rarely as single
cells.

While studying ECM control of single endothelial cell behavior without the

confounding contribution of cell-cell interaction is necessary, it is also crucial to develop
a more focused understanding of the role of cell-cell adhesion itself in endothelial cell
behavior, as well as how cell-cell interactions might affect ECM regulation of
multicellular vascular structures. For instance, culture of single endothelial cells on
adhesive islands of defined area results in a switch between proliferation with high cell
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spreading and apoptosis with low cell spreading (Chen et al., 1997). However, it is only
when endothelial cells are cultured on lines of fibronectin of intermediate width,
permitting multicellular interactions, that cells differentiate into capillary tube-like
structures (Dike et al., 1999). While cell-cell contact is traditionally thought to inhibit
endothelial cell proliferation (Caveda et al., 1996), our lab has observed proliferation
within confluent sheets of endothelial cells at regions of higher stress as dictated by the
surrounding ECM environment (Fig. 1.6A), suggesting that cytoskeletal tension
propagated through cell-cell contacts can be an important driver of proliferation in
physiological contexts (Nelson et al., 2005). These observations provide one potential
explanation for increased proliferation of stalk cells in angiogenic sprouts (Gerhardt et
al., 2003), with migrating tip cells pulling and propagating stress toward stalk cells at the
base of the sprouts. In addition to propagating tension, our lab has demonstrated that
cell-cell contact itself can activate cytoskeletal tension signaling and subsequent
proliferation.

VE-cadherin-mediated contact normally reduced the degree of cell

spreading and proliferation, but when cell spreading was kept constant via a
micropatterning technique, the presence of cell-cell contact actually promoted cell
proliferation via increased actomyosin-generated tension (Fig. 1.6B) (Nelson and Chen,
2002; Nelson and Chen, 2003). The decrease in cell-ECM adhesion by VE-cadherinmediated cell-cell adhesion could occur through several mechanisms: cell-cell contactinduced changes in the tension and structure of the actin cytoskeleton (Adams et al.,
1998), cadherin-induced decrease in the expression of integrins (Zhu and Watt, 1996),
and recruitment of vinculin to cell-cell contacts away from focal adhesions (Levenberg et
al., 1998). Conversely, integrin-mediated adhesion has been shown to disrupt
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Figure 1.6.

Multicellular interactions regulate angiogenesis.

(A) Confluent

monolayers of endothelial cells proliferate at regions of higher stress: at monolayer
edges (top) or in valleys of undulating monolayers without edges (bottom).

From

(Nelson et al., 2005). (B) Cell-cell contact increases proliferation when cell spreading is
controlled. From (Nelson and Chen, 2003).
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VE-cadherin-containing cell-cell junctions (Wang et al., 2006), potentially contributing to
the initiation of angiogenic sprouting and subsequent vascular morphogenesis. These
results highlight the complex interplay between cell-cell and cell-ECM adhesion and the
importance of understanding how they affect each other in the multicellular processes of
angiogenesis. In addition to the interaction between cell-cell and cell-ECM adhesion,
Dejana and colleagues have importantly shown that endothelial cell-cell adhesion can
regulate soluble VEGF signaling: engagement of VE-cadherin at cell-cell junctions can
sequester VEGF receptor 2 at the cell surface, preventing its internalization and
subsequent signaling from the receptor (Grazia Lampugnani et al., 2003; Lampugnani et
al., 2006). This reduction in VEGF signaling in confluent monolayers provides one
explanation for contact-dependent inhibition of proliferation and quiescence in confluent
endothelial cells.
In addition to the importance of homotypic endothelial cell interactions in
angiogenesis, several recent studies have explored the role of mesenchymal support cells
in inducing formation of and stabilizing vascular networks (reviewed in greater depth in
(Gerhardt and Betsholtz, 2003; Hughes, 2008)). Early work by D’Amore and colleagues
demonstrated recruitment of 10T1/2 pericytes toward developing vessels and their
differentiation to a smooth muscle fate by signals from endothelial cells (Hirschi et al.,
1998), as well as mutual inhibition of proliferation in pericytes and endothelial cells in
contacting co-cultures (Hirschi et al., 1999; Orlidge and D'Amore, 1987).

These

responses resulted from both soluble PDGF and TGF-β signals (Hirschi et al., 1998) and
direct N-cadherin contacts between endothelial cells and pericytes (Gerhardt et al., 2000).
The importance of pericytes in stabilizing vessels is evidenced by leaky, heterogeneous
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tumor blood vessels, which have incomplete pericyte coverage (Abramsson et al., 2002;
Eberhard et al., 2000; Yonenaga et al., 2005), as well as microvascular defects in PDGFB or PDGF beta-receptor knockout mice due to decreased pericyte recruitment (Enge et
al., 2002; Leveen et al., 1994; Soriano, 1994). As such, the majority of efforts to create
stable vascular networks in engineered tissues now incorporate mural support cells in
some form. Dermal fibroblasts seeded on the surface of fibrin gels are used to stimulate
capillary sprouting from endothelial cell-coated beads into the gels (Nakatsu et al., 2003),
extending previous work demonstrating stimulation of endothelial tubule formation by
3T3 fibroblasts (Montesano et al., 1993). The same endothelial sprouting assay can be
carried out with mesenchymal stem cells (MSCs) distributed throughout the matrix in
place of surface-seeded fibroblasts (Ghajar et al., 2006), and these interactions are
thought to occur primarily through secreted soluble factors. Others are employing direct
cell-cell interactions between endothelial and mural cells to stabilize the vasculature in
implanted tissues.

A recent report demonstrated that MSCs can in fact serve as

perivascular precursor cells by stabilizing endothelial cell networks implanted in vivo for
several months (Au et al., 2008), producing similar results as earlier work by this group
using 10T1/2 pericytes (Koike et al., 2004). Others have demonstrated the ability of
neural progenitor cells (Ford et al., 2006) and adipose stromal cells (Traktuev et al.,
2009) to stabilize vessels in vivo.

Perhaps the most intriguing finding relevant to

vascularizing tissues, though, is the discovery that empty basement membrane “sleeves”
and accompanying pericytes left behind after vessels regressed in response to inhibition
of

VEGF

receptor—a

potential

anti-tumor

treatment—quickly

revascularization upon withdrawal of the drug (Mancuso et al., 2006).
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promoted
Endothelial

sprouts grew into the basement membrane sleeves and fully revascularized the tumor by
7 days. While this study has obvious implications in cancer therapy, it also suggests that
perhaps ECM secreted by endothelial cells and pericytes can be used to guide and
vascularize engineered tissues efficiently.

While cell-secreted ECM is one way

endothelial cells might be regulated mechanically by pericytes, it remains to be seen
whether other means of interaction, for example pericyte-generated traction transmitted
through the matrix or alignment of matrix fibers, also have a significant impact on
endothelial cell behavior.

1.8 Summary
Angiogenesis is tightly regulated by many components of the cellular microenvironment,
from soluble factors to cell-ECM and cell-cell interactions. While ECM regulation of
angiogenesis has become a major topic of interest, it has been difficult to separate effects
of components of the ECM, including adhesive ligand presentation, mechanical
compliance, and degradability. In the following chapters, we use micropatterning and
synthetic hydrogel tools to control more precisely the interaction between endothelial
cells and the ECM to study its effect on angiogenesis. In Chapter 2, we describe the
effect of quantitative changes in adhesion on angiogenic sprouting and gene expression.
In Chapter 3, we uncover a mechanistic basis for this effect, demonstrating that Pyk2 is
responsible for enhanced gene expression and sprouting in limited adhesion contexts. In
Chapter 4, we introduce a synthetic PEG hydrogel whose mechanical, adhesive, and
degradable parameters can be tuned to study their independent effects on angiogenesis, as
well as to serve as a vascularizable scaffold for applications in tissue engineering.
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CHAPTER 2
DECREASED CELL ADHESION PROMOTES
ANGIOGENESIS

2.1 Introduction
Angiogenesis, or the development of new capillary blood vessels for tissue
vascularization, involves a coordinated cascade of numerous cellular processes, including
the activation of quiescent endothelium leading to degradation of the basement
membrane and interstitial matrix, initiation of sprouting from existing vessels via cell
proliferation and migration, and coordinated assembly of cells into branching tubules that
carry blood (Adams and Alitalo, 2007). It is therefore not surprising that angiogenesis
depends on a complex interplay between soluble growth factors and cellular adhesive
interactions with the ECM.
While a number of growth factors that promote angiogenesis have been identified,
the VEGF family is perhaps best described due to its roles in stimulating growth,
migration, and differentiation of endothelial cells into capillary tubes during both
developmental and pathological angiogenesis (Ferrara et al., 2003). Although VEGF is
31

known to stimulate endothelial cell proliferation in a dose-dependent manner (Ferrara and
Henzel, 1989), it is also known that VEGF levels must be tightly regulated in vivo, as
both a 50% reduction and a two- to three-fold increase in VEGF expression result in
embryonic lethality (Carmeliet et al., 1996; Ferrara et al., 1996; Miquerol et al., 2000),
and changes in the local concentration of VEGF can shift a normal, functional angiogenic
response to a pathological one with abnormal, leaky vessels (Ozawa et al., 2004). In
contrast to the detailed understanding of the contribution of such growth factors to
angiogenesis, much less is known about how cell adhesion to the ECM, and its many
complex facets, contributes to the regulation of angiogenesis.
Cell adhesion involves numerous interrelated steps, including binding of integrin
receptors to ECM ligands, assembly of focal adhesions, and cytoskeletal reorganization
as cells extend and spread against the matrix. Several elegant studies using knockouts or
blocking antibodies have identified a general role for integrins in angiogenesis
(Avraamides et al., 2008; Friedlander et al., 1995; Kim et al., 2000; Tanjore et al., 2008;
Yang et al., 1993) and suggest that there is not one particular integrin that is uniquely
involved in regulating angiogenesis.

Supporting this general adhesive requirement,

knockout of numerous cell adhesion-related proteins, including FAK, results in a
phenotype of embryonic lethality with severe vascular defects (Braren et al., 2006; Shen
et al., 2005). Together, these studies clearly show that integrin-mediated adhesion is an
absolute requirement for angiogenesis. However, in spite of this evidence, it still remains
unclear whether more subtle shifts in cell-matrix adhesive interactions might modulate
angiogenesis. We could reason that if blocking adhesion prevented angiogenesis, then
enhancing adhesion would promote it, and limiting adhesion would partially suppress it.
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Consistent with this model, it has been shown that increasing cell adhesion, by either
increasing ECM density or the area of cell contact with a substrate, stimulates capillary
endothelial cell proliferation, one step in the angiogenic process (Chen et al., 1997;
Ingber, 1990). However, it has also been reported that decreasing adhesion may enhance
cell-cell interaction and tubulogenesis, another important component of angiogenesis
(Dike et al., 1999; Ingber and Folkman, 1989). Thus, it remains unclear how changes in
the amount of cell-ECM adhesion might ultimately impact the amount or character of
angiogenesis.
In this chapter, we examined how changes in cell-ECM adhesion regulate VEGFinduced angiogenic sprouting and used gene expression profiling to further describe these
effects. We observed enhanced sprouting and expression of genes associated with an
invasive angiogenic phenotype with decreased adhesion.

We also investigated the

contributions of other microenvironmental properties—ECM stiffness and cell-cell
interaction—and observed enhanced angiogenic gene expression with decreased stiffness
and decreased cell-cell adhesion.

2.2 Materials and Methods
2.2.1 Cell culture
Human umbilical vein endothelial cells (HUVEC, provided by Guillermo GarcíaCardeña, Harvard University) were cultured in Medium 199 (Lonza) containing 20%
fetal bovine serum (FBS, Gibco), 100 units/ml penicillin, 100 μg/ml streptomycin, 50
μg/ml ECGS (Biomedical Technologies Inc.), and 100 μg/ml heparin (Sigma) up to
passage 7 on gelatin-coated culture surfaces. Starvation medium consisted of Medium
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199 with 5% FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin. Human adult
dermal microvascular endothelial cells (HMVEC-dAd, Lonza) were cultured in EGM2MV medium (Lonza). Starvation medium consisted of EGM-2MV medium containing
0.5% FBS. Human recombinant VEGF (R&D Systems) was used at 25 ng/ml unless
noted otherwise.
2.2.2 Sprouting assays
Aortic ring sprouting was carried out as described previously (Aplin et al., 2008;
Auerbach et al., 2003).

Aortic arches were isolated from 12-day-old white Leghorn

chick embryos (Charles River SPAFAS, Preston, CT), dissected into 1 mm-long
segments, and embedded into fibrin gels (human fibrinogen and thrombin from Sigma) of
defined density. Gels were maintained in EGM-2 medium (Lonza) and imaged 48 hours
later on an inverted microscope (Nikon Eclipse TE200) with SPOT RT3 camera
(Diagnostic Instruments, Inc.). For high-magnification imaging of endothelial cells in the
sprouts, aortic rings were incubated with 20 μg/ml rhodamine-labeled lectin (Lens
culinaris agglutinin; Vector Laboratories) for 30 minutes in EBM-2 prior to embedding.
After fixation 48 hours later in 4% paraformaldehyde, samples were imaged on an
inverted microscope (Zeiss Axiovert 200M) using a 40x 1.30 NA, oil immersion
objective (Zeiss) and Zeiss AxioCam HRm camera. Samples were imaged in 1 μm-thick
optical z-sections, which were deconvolved prior to creation of maximum intensity
projections. For endothelial spheroid sprouting assays, spheroids of HUVECs were made
as described previously (Korff and Augustin, 1998). Briefly, HUVECs were suspended
in a solution of EGM-2 containing 0.24% methylcellulose (Sigma) and deposited in nonadherent round-bottom 96-well plates (Nunc) to obtain 800 cells per well. The resulting
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spheroids were harvested 20-24 hours later and embedded into fibrin gels of defined
density. Cultures were maintained in EGM-2 medium and imaged 24 hours later as
above. Sprout lengths for all assays were quantified using Image J software (National
Institutes of Health).
2.2.3 Generation of micropatterned and ECM protein-coated substrates
Micropatterned substrates to control cell adhesion were generated as previously described
(Tan et al., 2004). Briefly, stamps containing arrays of squares were generated by casting
poly(dimethylsiloxane) (PDMS; Sylgard 184, Dow Corning) from silicon masters
patterned by photolithography. Stamps were immersed for 1 hour in an aqueous solution
of 20 μg/ml fibronectin (BD Biosciences), rinsed three times in water, and blown dry
with nitrogen.

They were then placed in conformal contact against UV ozone-treated

PDMS-coated culture surfaces, which were then blocked with 0.2% Pluronic F127
(BASF) for 1 hour and rinsed with PBS before cell seeding. Substrates with different
densities of adsorbed fibronectin, vitronectin, or laminin were generated by immersing
PDMS-coated surfaces in the specified concentration of ECM protein for 1 hour, rinsing
two times in water, blocking in 0.2% Pluronic F127 for 1 hour, and rinsing in PBS before
cell seeding.
2.2.4 Generation of polyacrylamide gel substrates
Polyacrylamide gels were prepared by polymerizing pre-specified concentrations of
acrylamide and bis-acrylamide to achieve the desired elastic modulus using a standard
free-radical polymerization with initiators (TEMED and ammonium persulfate) (Yeung
et al., 2005). 20 μg/ml fibronectin was conjugated to the surface by copolymerization of
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NHS-acrylate (Sigma) dissolved in toluene on top of the polymerizing acrylamide
solution as described (Kandow et al., 2007).
2.2.5 Microarray analysis
HUVECs were cultured on micropatterned islands (1764μm2) of fibronectin or allowed to
spread fully for 2 hours and then stimulated with 50ng/ml VEGF or no growth factor for
18 hours in starvation medium. Sample RNA from each of 3 replicates was isolated
using the Qiagen RNeasy Mini Kit and prepared for hybridization to microarrays as
described in the Affymetrix GeneChip Expression Analysis Technical Manual. Briefly, 2
μg of total RNA was converted to first-strand cDNA using Superscript II reverse
transcriptase primed by a poly(T) oligomer that incorporated the T7 promoter. Secondstrand cDNA synthesis was followed by in vitro transcription for linear amplification of
each transcript and incorporation of biotinylated CTP and UTP. The cRNA products
were fragmented to 200 nucleotides or less, heated at 99ºC for 5 minutes and hybridized
for 16 hours at 45ºC to Affymetrix Human Genome U133 Plus 2.0 GeneChip expression
microarrays. The microarrays were then washed at low (6X SSPE) and high (100 mM
MES, 0.1 M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence
was amplified by adding biotinylated anti-streptavidin and an additional aliquot of
streptavidin-phycoerythrin stain. A confocal scanner was used to collect fluorescence
signal at 3 μm resolution after excitation at 570 nm. The average signal from two
sequential scans was calculated for each microarray feature.

GCRMA-normalized

expression data from each microarray were deposited in NCBI’s Gene Expression
Omnibus and are accessible through GEO Series accession number GSE19098 at the
following link: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE19098.
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2.2.6 Real-time gene expression analysis
Sample RNA was isolated using the Qiagen RNeasy Micro Kit, then quantified using a
UV spectrophotometer (Becton Dickinson) at 260 nm and 280 nm. RNA was then
reverse-transcribed using M-MLV RT (Invitrogen), and the resulting cDNA was
amplified using Taqman gene expression assay primers (Applied Biosystems) on an
Applied Biosystems 7300 real-time PCR instrument. Gene expression values represent
ΔΔCt normalized to GAPDH and the indicated spread or high fibronectin density control
condition in all experiments.
2.2.7 Quantification of focal adhesions
Focal adhesions were quantified as previously described (Nelson et al., 2004). Briefly,
cells were incubated for 1 minute in ice-cold cytoskeleton buffer (50 mM NaCl, 150 mM
sucrose, 3 mM MgCl2, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin, and 2
mM PMSF), followed by 1 minute in cytoskeleton buffer containing 0.5% Triton X-100.
Detergent-extracted cells were fixed in 4% paraformaldehyde in PBS for 20 minutes,
blocked in 33% goat serum for 1 hour, and incubated with a primary antibody to vinculin
(hVin1, Sigma-Aldrich), followed by incubation with Alexa Fluor 594–conjugated
secondary antibodies (Invitrogen). Samples were imaged on an inverted microscope
(Zeiss Axiovert 200M) with a 63x 1.40 NA, oil immersion objective and a Zeiss
AxioCam HRm camera using Zeiss AxioVision software. Images were filtered and
binarized using Matlab, and adhesions over 0.5 μm2 counted toward the overall focal
adhesion number per cell.
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2.3 Results
2.3.1 Decreased fibrin density enhances angiogenic sprouting
To begin to explore the effects of modulating cell-ECM adhesion on angiogenic
sprouting, we adopted a simple but robust assay in which explanted embryonic chick
aortic arches (E12) are sectioned into rings and embedded into fibrin gels (Aplin et al.,
2008; Auerbach et al., 2003). In this model, endothelial cells within the aortic tissue
rapidly invade the surrounding fibrin, forming multicellular, tube-like structures. To
examine the effect of changing adhesion, we varied the density of fibrin by polymerizing
gels with fibrinogen ranging from 2.5 to 20 mg/ml. There was a gradual increase in
sprouting with decreasing fibrin density, which plateaued below 5 mg/ml due to the
mechanical weakness of lower density gels. By 48 hours the average length of sprouts in
5 mg/ml fibrin gels was twice that in 20 mg/ml fibrin gels (Fig. 2.1A,C). Interestingly,
not just the degree but also the character of sprouting appeared to be modulated by
adhesion, with longer, more sparsely arranged sprouts in low density fibrin gels
contrasting shorter, more densely packed sprouts in high density fibrin gels. Labeling the
samples with an endothelial cell-specific lectin confirmed that the majority of cells within
the sprouts were endothelial cells (Fig. 2.1B).
While the aortic ring assay offered the advantage of recreating in vivo-like
sprouting supported by mesenchymal cells, this added complexity also made it difficult to
assess whether the observed adhesion effect could be attributed to a direct interaction
between the ECM and endothelial cells alone. To address this, we examined whether
fibrin density could modulate sprouting from spheroids of pure endothelial cells.
HUVECs were clustered into multicellular spheroids, embedded into fibrin, and allowed
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to sprout from the spheroids. Again, we observed significantly enhanced sprouting in
low density as compared to high density fibrin gels, with longer and more numerous
sprouts (Fig. 2.1D,E). Thus, it appears that limited adhesion from decreased matrix
density enhances angiogenesis.
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Figure 2.1. Decreased fibrin density enhances angiogenic sprouting. (A) Sprouting
of chick aortic rings embedded in 5 mg/ml (left) versus 20 mg/ml (right) fibrin at 48
hours, bar = 500 μm. (B) Endothelial cells in sprouts labeled with lectin (red) and
Hoechst 33342 (blue), bar = 20 μm. (C) Quantification of average sprout length for chick
aortic rings in 5 mg/ml versus 20 mg/ml fibrin. Graph represents means ± SEM over 4
independent experiments, with each experiment averaged over at least 3 aortic rings. (D)
Sprouting of HUVEC spheroids embedded in 5 mg/ml (left) versus 20 mg/ml (right)
fibrin gels at 24 hours, bar = 100 μm. (E) Quantification of average sprout length and
average number of sprouts per spheroid in 5 mg/ml versus 20 mg/ml fibrin. Graphs
represent means ± SEM over 4 independent experiments, with each experiment averaged
over at least 4 spheroids. *, p < 0.05, as calculated by Student’s t-test.
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2.3.2 Adhesion regulates the expression of genes associated with angiogenesis
Because varying fibrin gel density could alter numerous factors important to
angiogenesis in addition to cell adhesion, we next examined whether more precise
methods to limit the degree of cell adhesion could similarly induce an activated
angiogenic phenotype. We utilized two approaches to modulate cell-ECM adhesion: one
involves coating substrates with different densities of fibronectin to control ECM
availability (Ingber and Folkman, 1989), and the other involves micropatterning
substrates with different sizes of fibronectin-coated islands to control the physical area of
cell-ECM contact (Fig 2.2A) (Chen et al., 1997). We selected adhesive conditions for
this study in which adhesion would be either maximal or approximately half of maximal,
as measured by quantification of focal adhesions.

We cultured HUVECs on

micropatterned islands of fibronectin (1764 μm2, “unspread”) or low density (5 μg/ml)
fibronectin (average cell spreading area 1750 μm2), as compared to cells allowed to
spread fully on surfaces coated with high density (20 μg/ml) fibronectin (average area
3200 μm2, “spread”). Staining for focal adhesions verified that both unspread cells and
cells cultured on low density fibronectin had significantly fewer adhesions than spread
cells (Fig. 2.2B).
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Figure 2.2.

Use of microcontact printing or fibronectin density to control cell

adhesion. (A) Method to control cell spreading by microcontact printing. (B) Cell
spreading is controlled by constraining cells to micropatterned islands of fibronectin
(“unspread,” 1764 μm2 area, high density fibronectin) or reducing fibronectin density, as
compared to fully spread cells on high density fibronectin (“spread”). Phase images in
top row, bar = 50 μm. Immunofluorescent images in bottom row with vinculin (green)
and Hoechst 33342 (blue), bar = 20 μm. The average focal adhesion number per cell is
quantified for each condition. Data represent means ± SD (15 cells per condition). *, p <
0.05 versus high fibronectin density, as calculated by one-way ANOVA and post-hoc
Tukey’s HSD test.
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While these well-defined adhesive contexts offer an approach to isolate the
specific effects of cell-ECM adhesion, they do not support the complex invasion and
sprouting behavior observed in the fibrin gels. As such, to characterize the phenotype of
endothelial cells cultured on these substrates, we examined global gene expression
changes by microarray analysis. HUVECs were cultured on micropatterned islands of
fibronectin or allowed to spread fully for 2 hours and then stimulated with 50 ng/ml
VEGF or no growth factor for 18 hours in starvation medium.

ANOVA analysis

indicated that many genes (1,641 out of 28,970) changed expression at least 2-fold in
response to changes in adhesion alone (Fig. 2.3A). In contrast, only a small subset of
genes (108) was upregulated at least 2-fold in response to VEGF in highly adherent, wellspread cells, highlighting the dramatic effects of adhesion on global gene expression in
endothelial cells. Interestingly, substantially more genes (521) responded to VEGF in
unspread cells, indirectly hinting at the possibility that the response to VEGF may be
enhanced in the context of limited cell adhesion.

Among the genes most highly

upregulated in unspread cells in the presence of VEGF were matrix Gla protein (MGP),
an insoluble matrix protein that binds vitronectin and regulates arterial calcification (Luo
et al., 1997; Nishimoto and Nishimoto, 2005); stanniocalcin 1 (STC1), a gene involved in
endothelial cell migration (Zlot et al., 2003) and highly upregulated in several
microarrays of angiogenesis (Bell et al., 2001; Gerritsen et al., 2002); RhoGAP6
(ARHGAP6), a Rho GTPase activating protein; and dickkopf homolog 2 (DKK2), a
regulator of Wnt signaling (Wu et al., 2000) (Fig. 2.3B).
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Figure 2.3.

Decreased cell adhesion promotes global upregulation of genes in

response to VEGF. (A) HUVECs were cultured in four conditions (spread no VEGF,
spread with VEGF, unspread no VEGF, unspread with VEGF) for 18 hours, after which
gene expression was analyzed by microarray. Pairwise comparison shows of numbers of
genes changing expression at least 2-fold between the conditions listed. “Upregulated”
denotes genes expressed higher in the first condition of each pair, and “downregulated”
denotes genes expressed higher in the second condition of each pair. (B) Lists of genes
most highly up- or down-regulated with changes in spreading in the presence of VEGF,
as well as in unspread cells with or without exposure to VEGF.
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Figure 2.4. Adhesion regulates the expression of genes associated with angiogenesis.
Heatmap of expression of genes associated with angiogenesis in four conditions (spread
no VEGF, spread with VEGF, unspread no VEGF, unspread with VEGF) after 18 hours
of culture.

Heatmap values represent log-transformed ratios of expression in one

condition to the average expression value over all conditions for a given gene, averaged
over three replicates. Genes are clustered based on similarities in expression patterns
using Ward’s hierarchical clustering method.
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Importantly, when focusing only on genes previously associated with
angiogenesis (genes associated with Gene Ontology category of angiogenesis, as well as
genes previously described to be upregulated in models of angiogenesis (Bell et al., 2001;
Gerritsen et al., 2002)), a majority were upregulated in unspread cells as compared to
spread cells (Fig. 2.4).

These upregulated genes primarily belonged to functional

groupings such as angiogenic growth factor signaling, cell-ECM adhesion and migration,
cell-cell adhesion, and matrix invasion. Together, this constellation was representative of
an activated angiogenic phenotype. In contrast, genes upregulated in spread cells were
primarily associated with proliferation. These results were consistent with previous
studies demonstrating increased proliferation with greater cell adhesion and spreading
and increased tubulogenesis with decreased adhesion (Chen et al., 1997; Ingber, 1990;
Ingber and Folkman, 1989).

We confirmed the expression of several genes by

quantitative real-time PCR in HUVECs and HMVEC-dAds (Fig. 2.5), including: Eph
receptor A7 (EPHA7), a member of the ephrin tyrosine kinase receptor family that, along
with ephrin ligands, mediate cell-cell communication important for vessel sprouting and
morphogenesis (Zhang and Hughes, 2006); STC1 (described above); membrane type 1
MMP (MMP14), a matrix metalloproteinase required for vascular invasion (Collen et al.,
2003; Hiraoka et al., 1998); and cyclin D1 (CCND1), a cyclin required for G1/S
progression in the cell cycle known to regulate endothelial cell proliferation (Yasui et al.,
2006). We observed a similar expression pattern in cells cultured on high versus low
densities of fibronectin (Fig. 2.6A), as well as on high and low densities of vitronectin
and laminin (Fig. 2.6B) to confirm the effect was not restricted to fibronectin. These
results demonstrate that limiting cell adhesion through multiple mechanisms, whether via
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changes in ligand density or cell spreading, induced the expression of genes associated
with the invasive processes of angiogenesis, and were consistent with our observations of
enhanced sprouting in lower density fibrin gels.
In

addition

to

cell

adhesion,

we

investigated

the

roles

of

other

microenvironmental properties that could impact angiogenic sprouting—matrix stiffness
and cell-cell interaction—in regulating angiogenic gene expression. Using fibronectincoupled polyacrylamide gels to vary stiffness, we observed increased angiogenic gene
expression in cells cultured on soft versus stiff substrates (Fig. 2.7A), which is also
consistent with enhanced sprouting in lower density fibrin gels. This result could signify
an important independent role of ECM stiffness in regulating gene expression or result
from changes in cell spreading and adhesion signaling in soft versus stiff conditions. To
examine the role of cell-cell contact, we measured gene expression in confluent
endothelial cells compared to single endothelial cells of similar spread areas. While we
observed high gene expression in single endothelial cells cultured in limited adhesive
contexts, this response was inhibited in confluent endothelial cells (Fig. 2.7B). This
result suggests an important role for cell-cell adhesion in regulating gene expression and
could potentially explain differences in behavior between quiescent endothelial cells in
monolayers versus actively sprouting cells.
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Figure 2.5. Confirmation of gene expression in HUVECs and HMVECs. HUVECs
(A) and HMVEC-dAds (B) were cultured as spread or unspread, in starvation medium
with or without 25 ng/ml VEGF for 16-18 hours and analyzed for expression of select
genes by quantitative real-time PCR analysis (EPHA7 = Eph Receptor A7, MMP14 =
Membrane type 1 MMP, STC1 = Stanniocalcin 1, CCND1 = Cyclin D1). Data represent
means ± SEM (n ≥ 3). *, p < 0.05 compared to the spread condition, and +, p < 0.05
compared to no VEGF control, as calculated by two-way ANOVA and post-hoc Tukey’s
HSD test. #, p < 0.05 compared to the spread condition, as calculated by Student’s t-test
(not significant by ANOVA).
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Figure 2.6.

Decreased ECM ligand density promotes the expression of genes

associated with angiogenesis. (A) HUVECs were cultured on high (20 μg/ml) or low (5
μg/ml) density fibronectin, in starvation medium with or without 25 ng/ml VEGF for 1618 hours and analyzed for expression of select genes by quantitative real-time PCR
analysis. Data represent means ± SEM (n = 3). (B) HUVECs were cultured on high (20
μg/ml) or low (5 μg/ml) density fibronectin, vitronectin, or laminin, in starvation medium
containing 25 ng/ml VEGF for 16-18 hours and analyzed for expression of select genes
by quantitative real-time PCR analysis. Data represent means ± SEM (n = 3).
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Figure 2.7. Decreased ECM stiffness and cell-cell contact promote the expression of
genes associated with angiogenesis. (A) HUVECs were cultured on soft (400 Pa) and
stiff (5 kPa) fibronectin-coupled polyacrylamide gels, in starvation medium with or
without 25 ng/ml VEGF for 16-18 hours and analyzed for expression of select genes by
quantitative real-time PCR analysis. Data represent means ± SEM (n = 3). *, p < 0.05
compared to the 5 kPa condition, and +, p < 0.05 compared to no VEGF control, as
calculated by two-way ANOVA and post-hoc Tukey’s HSD test.

(B) HUVECs were

cultured as spread, unspread, or confluent, in starvation medium with or without 25 ng/ml
VEGF for 16-18 hours and analyzed for expression of select genes by quantitative realtime PCR analysis. Data represent means ± SEM (n = 3). *, p < 0.05 compared to the
unspread condition, and +, p < 0.05 compared to no VEGF control, as calculated by twoway ANOVA and post-hoc Tukey’s HSD test.
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2.4 Discussion
The role of multiple adhesive states in angiogenesis
Previous studies have demonstrated enhanced endothelial cell proliferation with
increased cell spreading and ECM density (Chen et al., 1997; Ingber, 1990), and
inhibition of either endothelial proliferation or cell-ECM adhesion are proven mainstay
strategies for developing anti-angiogenic therapies (Avraamides et al., 2008; Ferrara and
Kerbel, 2005). As a result, it has largely been assumed that angiogenesis would be
optimal in highly adhesive contexts.

It was therefore unexpected that we initially

observed a role for limited adhesion in promoting capillary sprouting. Previous reports
had described increased tubulogenesis with limited cell adhesion and spreading in vitro in
assays reminiscent of vasculogenesis (Dike et al., 1999; Ingber and Folkman, 1989), but
the relevance of these findings to angiogenesis had remained unclear. Interestingly, here
we revealed that this limited adhesion context drives sprouting in part by stimulating an
activated endothelial phenotype associated with vascular invasion and remodeling, which
can now be characterized by a specific gene expression profile. It has recently been
shown that increasing matrix compliance, which in other studies is thought to suppress
integrin activation (Paszek et al., 2005), appears to enhance VEGF responsiveness of
endothelial cells and angiogenesis in vivo (Mammoto et al., 2009). Another recent study
has also reported that low concentrations of integrin antagonists, under development as
anti-angiogenic cancer therapeutics, actually promote angiogenesis (Reynolds et al.,
2009). Our studies here point to one mechanism by which both the matrix compliance
and integrin antagonist effects could be explained.
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The fact that differences in the degree of cell-ECM adhesion could promote
distinct (proliferative versus invasive) endothelial cell behaviors important for
angiogenesis may have implications in numerous settings. Because angiogenesis is a
complex, multi-step process, it is possible that these different cellular behaviors are
stimulated in different stages of angiogenesis: enhanced MMP production and ECM
degradation at the sprouting tips (Yana et al., 2007) could limit adhesion and thereby
promote migration and cellular invasion, and increased ECM deposition along the stalks
could be responsible for the observed proliferation in these regions (Gerhardt et al.,
2003). Notably, our microarray analysis identified upregulation of genes associated with
tip cells—VEGFR-2/KDR, PDGF-B, and MT1-MMP/MMP14 (Gerhardt et al., 2003;
Yana et al., 2007)—in cells with limited adhesion exposed to VEGF, suggesting that
adhesive gradients may indeed play an important role in dictating the diverse cell
behaviors that are coordinated along angiogenic sprouts. Extending these implications to
the pathologic settings of matrix-dense tumors and fibrotic tissue, it is possible that the
altered degree of adhesive interactions may contribute to the abnormal angiogenesis in
these settings as much as excessive soluble growth factor stimulation, which is widely
cited as a key promoter of pathological angiogenesis (Carmeliet, 2005; Ozawa et al.,
2004). Thus, while it has previously been shown that integrins and integrin-mediated
adhesion are required for angiogenesis, the data presented here suggest a substantially
more subtle interplay between changes in the degree of adhesion and endothelial cell
phenotypes, which likely contributes to the complex staging of multiple behaviors
necessary to generate new capillary beds.

52

CHAPTER 3
PYK2 MEDIATES ANGIOGENESIS PROMOTED BY
LIMITED ADHESION

3.1 Introduction
To determine a mechanistic basis for the enhanced gene expression and sprouting
observed in limited adhesive contexts in Chapter 1, we examined the roles of several
molecules known to transduce adhesion signals—including ERK, ROCK, Src family
kinases, and FAK. Integrins signal through molecules such as Src and FAK, which aid in
focal contact turnover required for cell migration and invasion (Stupack and Cheresh,
2004). FAK is required for embryonic vascular development in vivo (Braren et al., 2006;
Shen et al., 2005), and its coupling to integrin αvβ5 by Src is critical for VEGF signaling
in endothelial cells and activates the Ras-Raf-ERK pathway downstream (Eliceiri et al.,
2002). ERK signaling promotes proliferation, survival, and migration of endothelial cells
(Stupack and Cheresh, 2004), and sustained ERK activation by growth factors has been
shown to require integrin ligation and is required for in vivo angiogenesis (Eliceiri et al.,
1998; Perruzzi et al., 2003; Stupack and Cheresh, 2004). RhoA signaling has been shown
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to be essential for VEGF-induced in vivo angiogenesis and in vitro endothelial cell
migration and capillary morphogenesis (Bryan and D'Amore, 2007; van Nieuw
Amerongen et al., 2003). While most of these molecules did not appear to play a
significant role in regulating gene expression promoted by limited adhesion, we did find
that Pyk2 (also known as RAFTK, CAK-β, or CADTK), a FAK family non-receptor
tyrosine kinase, regulates both gene expression and endothelial sprouting through its
enhanced activation by VEGF in limited adhesion conditions.
Further downstream, we sought to identify transcription factors that might be
responsible for regulating the gene expression patterns observed. We used CARRIE
analysis to identify several transcription factors, including STAT5 (A and B), heat shock
factor 1 and 2, hepatic nuclear factor 1, and cMyc/Max, that may be important in
regulating gene expression responses to changes in cell adhesion and VEGF exposure.

3.2 Materials and Methods
All cells, culture substrates, sprouting assays, and real-time gene expression analyses
were used or conducted as in Chapter 2.
3.2.1 Reagents
The MEK inhibitor U0126 (Calbiochem), ROCK inhibitor Y-27632 (Tocris), and Src
family kinase inhibitor PP2 (Calbiochem) were all used at 10 μM. The FAK inhibitor
PF-573228 (Tocris Bioscience) and Pyk2 inhibitor PF-0494755 (gift, Leonard
Buckbinder, Pfizer) were used at 500 nM unless noted otherwise.

Adenoviruses

harboring GFP, FRNK, and wild-type FAK were generated as described previously
(Pirone et al., 2006). Adenoviruses for expression of β-galactosidase (control) and Pyk2
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shRNA, as well as wild-type Pyk2 were provided by Leonard Buckbinder (Pfizer,
Groton, CT). Cells were infected with β-gal and Pyk2 shRNA adenoviruses at a MOI of
200.
3.2.2 Immunoblotting
Cells were rinsed in PBS and lysed in ice-cold RIPA buffer (1% Triton X-100, 150 mM
sodium chloride, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0, 1 mM
sodium orthovanadate, 5% (v/v) β-mercaptoethanol, and 1 μg/ml each aprotinin,
leupeptin, pepstatin, and PMSF). Proteins were separated by SDS-PAGE, transferred to
PVDF membranes, and blocked with 5% BSA or 5% milk in TBS-T as recommended for
each antibody. Blots were probed with antibodies against total FAK (clone 77, BD
Biosciences), phosphorylated FAK (Y397, Biosource), FRNK (06-543, Millipore), total
Pyk2 (clone 11, BD Biosciences), phosphorylated Pyk2 (Y402, Biosource), and GAPDH
(clone 6C5, Ambion), followed by horse radish peroxidase-conjugated secondary
antibodies (Jackson ImmunoResearch) and SuperSignal West Dura chemiluminescent
detection (Pierce).

Densitometric analysis was performed using a VersaDoc digital

imaging system with QuantityOne software (BioRad).

3.3 Results
3.3.1 FAK and Src family kinases may regulate limited adhesion-induced angiogenic
gene expression; ERK and ROCK are not major regulators of gene expression
To study the roles of ERK, ROCK, FAK, and Src family kinases in mediating
limited adhesion-induced gene expression, we cultured HUVECs in spread or unspread
conditions in the presence of VEGF and either the MEK inhibitor U0126, the ROCK
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inhibitor Y-27632, the FAK inhibitor PF-573228 (“PF228”), or the Src family kinase
inhibitor PP2 for 16-18 hours and analyzed for gene expression. ERK and ROCK
inhibition had no significant effect on gene expression in either spread or unspread cells
(Fig. 3.1A,B). FAK and Src family kinase inhibition, however, did result in a decrease in
gene expression in unspread cells (Fig. 3.1C,D). These results suggest that signals from
cell adhesion to integrins, as opposed to cytoskeletal tension, are primarily responsible
for the VEGF-induced gene expression observed. Given the difficulty of studying and
determining the individual roles of members of the Src family kinases, we decided to
explore further the role of FAK in regulating angiogenic gene expression.

56

Figure 3.1. FAK and Src family kinases may regulate limited adhesion-induced
angiogenic gene expression; ERK and ROCK are not major regulators of gene
expression. Gene expression of HUVECs after 16-18 hours of culture in spread or
unspread conditions with or without VEGF stimulation and 10 μM U0126 (A), 10 μM Y27632 (B), 5 μM PF228 (C), or 10 μM PP2 (D).
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3.3.2 FAK is not a major regulator of limited adhesion-induced angiogenic gene
expression
To investigate the role of FAK in VEGF-induced gene expression more
specifically, we expressed wild-type FAK or FRNK, the dominant-negative C-terminal
fragment of FAK, in HUVECs using recombinant adenoviruses and confirmed that these
treatments increased or decreased FAK signaling, respectively (Fig. 3.2A).

FAK-,

FRNK-, and control GFP-expressing cells were cultured in spread or unspread conditions
with or without VEGF exposure for 16-18 hours and analyzed for gene expression.
While expression of FAK and FRNK had no significant effect on the expression of
CCND1 and EPHA7 in all adhesive and soluble contexts, FRNK expression did rescue
VEGF-induced STC1 expression in spread cells to levels greater than in control unspread
cells (Fig. 3.2B). This isolated result provided a faint suggestion that the absence of FAK
signaling—whether through decreased adhesion or expression of FRNK—may promote
the expression of some genes associated with angiogenesis. However, in general, FAK
did not appear to explain many of our observations.
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Figure 3.2. FAK is not a major regulator of limited adhesion-induced angiogenic
gene expression. (A) Western blot of phospho-Y397-FAK, total FAK, FRNK, phosphoY402-Pyk2, total Pyk2, and GAPDH in GFP-, FAK-, and FRNK-overexpressing
HUVECs on both high (20 μg/ml) and low (5 μg/ml) density fibronectin-coated surfaces.
(B) Gene expression of GFP-, FRNK-, and FAK-overexpressing HUVECs after 16-18
hours of culture in spread or unspread conditions with or without VEGF stimulation.
Data represent means ± SEM (n = 3). *, p < 0.05 compared to GFP, as calculated by
three-way ANOVA and post-hoc Tukey’s HSD test.
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3.3.3 Pyk2 regulates the expression of genes associated with angiogenesis
The discrepancy in results between the pharmacological FAK inhibitor and FAK
and FRNK adenoviruses can likely be explained by the lack of specificity of the inhibitor
at the dose used (5 μM) in the previous experiments. Indeed, at that dose, the inhibitor
also targets a structurally related homologue of FAK, Pyk2. While endothelial cellspecific knockout of FAK has been shown to be embryonic lethal (Braren et al., 2006;
Shen et al., 2005), inducible knockout of FAK in adult endothelial cells does not affect
angiogenesis due to a compensatory upregulation of Pyk2 (Weis et al., 2008). Pyk2 is
activated by a number of extracellular signals, including growth factors and ECM
adhesion (Lev et al., 1995; Zheng et al., 1998).

However, unlike FAK, which is

ubiquitously expressed, Pyk2 is restricted to primarily hematopoietic and neuronal
tissues, with upregulation in a broader group of tissues later in development (Avraham et
al., 1995; Sasaki et al., 1995), and thus its role in angiogenesis is poorly understood. In
addition to its compensatory role for FAK in adult angiogenesis, Pyk2 has been shown to
be involved in endothelial cell spreading and migration (Avraham et al., 2003), VEcadherin-mediated cell-cell adhesion (van Buul et al., 2005), and neovessel formation
(Matsui et al., 2007; Tang et al., 2002). However, the effect of different adhesive
contexts on its role in angiogenesis has not been explored.
To investigate the role of Pyk2 in regulating angiogenic gene expression in
different adhesive contexts, we first knocked down expression of Pyk2 using a targeted
shRNA (Fig. 3.3A) and cultured Pyk2 and control (β-gal) shRNA-expressing HUVECs in
spread or unspread conditions with or without VEGF exposure for 16-18 hours. Pyk2
knockdown led to a significant decrease in the expression of EPHA7 and STC1 in
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unspread cells exposed to VEGF, to levels similar to wild type spread cells stimulated
with VEGF (Fig. 3.3B). In order to obtain a broader understanding of the importance of
Pyk2 in angiogenic gene expression, we screened numerous additional genes associated
with angiogenesis that were upregulated by VEGF and/or limited adhesion and found that
many but not all appeared to be suppressed with Pyk2 knockdown (Fig. 3.3C).
While these data suggest that Pyk2 is necessary for VEGF-induced gene
expression in limited adhesive contexts, it is not clear whether Pyk2 activity is sufficient
for controlling angiogenic gene expression. To address this possibility, we overexpressed
wild-type Pyk2 (Fig. 3.4A) and placed cells in high versus low adhesive contexts, with
and without VEGF stimulation. Although Pyk2 alone could not initiate angiogenic gene
expression, it rescued EPHA7 and STC1 expression in fully spread cells in response to
VEGF (Fig. 3.4B), indicating Pyk2 was necessary and sufficient for transducing the low
adhesive context that supports VEGF responsiveness. Interestingly, CCND1 expression
was not affected by Pyk2 manipulation, suggesting that only genes normally upregulated
by decreased adhesion and associated with an activated endothelial phenotype—and not
those associated with proliferation—are regulated by Pyk2.
One mechanism by which Pyk2 might promote gene expression only in limited
adhesive contexts is if limited cell-ECM adhesion rendered Pyk2 more responsive to
soluble VEGF stimulation than highly adhesive conditions. To explore this possibility,
we measured Pyk2 activity in response to VEGF in HUVECs cultured on high and low
densities of fibronectin. We observed two-fold greater activity in cells cultured on low
density versus high density fibronectin (Fig. 3.5), confirming that reduced adhesion in
fact enhances Pyk2 activation by VEGF.
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Figure 3.3.

Pyk2 knockdown inhibits the expression of genes associated with

angiogenesis. (A) Expression of Pyk2 mRNA in spread versus unspread HUVECs
transfected with control (β-gal) versus Pyk2 shRNA. Data represent means ± SEM (n =
4). *, p < 0.05, as calculated by three-way ANOVA and post-hoc Tukey’s HSD test. (B)
Gene expression of HUVECs transfected with control versus Pyk2 shRNA after 16-18
hours of culture in spread or unspread conditions with or without VEGF stimulation.
Data represent means ± SEM (n = 3). *, p < 0.05, as calculated by three-way ANOVA
and post-hoc Tukey’s HSD test. (C) Additional genes associated with angiogenesis that
were upregulated by limited adhesion, VEGF stimulation, or both are shown as
suppressed or not suppressed by Pyk2 knockdown, as measured by real-time PCR.
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Figure 3.4. Pyk2 overexpression rescues the expression of genes associated with
angiogenesis. (A) Western blot of phospho-Y402-Pyk2, total Pyk2, phospho-Y397FAK, total FAK, and GAPDH in GFP- and Pyk2-overexpressing HUVECs on both high
(20 μg/ml) and low (5 μg/ml) density fibronectin-coated surfaces. (B) Gene expression
of GFP- and Pyk2-overexpressing HUVECs after 16-18 hours of culture in spread or
unspread conditions with or without VEGF stimulation. Data represent means ± SEM (n
= 3). #, p < 0.05, as calculated by Student’s t-test (not significant by ANOVA).
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Figure 3.5. VEGF-induced Pyk2 activity is increased by limited adhesion. Western
blot of phospho-Y402-Pyk2, total Pyk2, and GAPDH in HUVECs cultured on high (20
μg/ml) and low (5 μg/ml) density fibronectin-coated surfaces with or without VEGF
stimulation.

Graph shows quantification of 4 independent experiments, where data

represent means ± SEM and *, p < 0.05, as calculated by two-way ANOVA and post-hoc
Tukey’s HSD test.
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3.3.4 Pyk2 regulates angiogenic sprouting in low adhesion conditions
Our studies uncovered a role for Pyk2 in regulating the expression of several
genes involved in angiogenesis. However, it remained unclear whether these effects on
gene expression would ultimately impact the physical process of angiogenic sprouting.
To investigate this possibility, we examined whether Pyk2 manipulation would impact
sprouting from endothelial spheroids in high and low density fibrin gels.

We also

compared the effects of FAK manipulation to confirm whether its effects on sprouting are
consistent with the minimal role for FAK we observed in the gene expression studies.
Unfortunately, adenoviral infection of the HUVECs appeared to alter their ability to form
the tightly packed spheroids required in this assay, so we inhibited Pyk2 with the
pharmacological inhibitor PF-04594755 (“PF755” (Bonnette et al.)) and FAK with the
pharmacological inhibitor PF228, choosing concentrations based on maximal inhibition
of the target kinase and minimal inhibition of the other (Fig. 3.6A,B). Pyk2 inhibition
with 500 nM PF755 significantly decreased sprouting in low density gels compared to
controls but had no effect on sprouting in high density gels, consistent with a specific role
for Pyk2 in low adhesion-induced angiogenesis. FAK inhibition with 500 nM PF228 had
no significant effect, and Pyk2 and FAK inhibition together had the same effect as Pyk2
inhibition alone (Fig. 3.7A,B), suggesting a minimal role for FAK in these studies.
Similarly, sprouting from chick aortic rings was significantly reduced with PF755,
although FAK inhibition with PF228 also inhibited sprouting in low density gels but to a
lesser extent, and the two inhibitors together resulted in a synergistic reduction of
sprouting (Fig. 3.8A,B). The reduction of sprouting by FAK inhibition in aortic rings but
not pure endothelial spheroids raises a possibility that the inhibitor is targeting supporting
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mesenchymal cells as opposed to the endothelium. Taken together, these results mirror
gene expression patterns in that inhibition of Pyk2 reduces sprouting in limited adhesive
conditions to levels similar to those in high adhesive conditions, thus demonstrating a
role for Pyk2 in transducing limited adhesive signals to promote angiogenic gene
expression and sprouting.

Figure 3.6. Dosing of FAK and Pyk2 inhibitors. FAK and Pyk2 phosphorylation in
HUVECs in response to 0, 0.1, 0.5, or 1 μM of PF-573228 (“PF228,” FAK inhibitor) (A)
or PF-04594755 (“PF755,” Pyk2 inhibitor) (B). Graphs show quantification of FAK and
Pyk2 activity (ratio of phosphorylated to total protein), normalized to DMSO (no drug)
control.
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Figure 3.7.

Pyk2 regulates endothelial spheroid sprouting in low adhesion

conditions. (A) Sprouting of HUVEC spheroids in the presence of 500 nM of PF228,
PF755, or both in combination as compared to DMSO control in low (5 mg/ml) versus
high (20 mg/ml) density fibrin. Bar, 100 μm. (B) Quantification of average sprout length
and sprout number over 4 independent experiments, with each experiment averaged over
at least 3 spheroids. Data represent means ± SEM. *, p < 0.05 versus DMSO control, as
calculated by one-way ANOVA and post-hoc Tukey’s HSD test. #, p < 0.05 versus
DMSO control, as calculated by Student’s t-test (not significant by ANOVA).
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Figure 3.8.

Pyk2 regulates ex vivo sprouting in low adhesion conditions.

(A)

Sprouting of aortic rings in the presence of 500 nM of PF228, PF755, or both in
combination as compared to DMSO control in low (5 mg/ml) versus high (10 mg/ml)
density fibrin.

Bar, 300 μm.

(B) Quantification of average sprout length over 3

independent experiments, with each experiment averaged over at least 2 aortic rings.
Data represent means ± SEM. *, p < 0.05, as calculated by one-way ANOVA and posthoc Tukey’s HSD test.
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3.3.5 Transcription factors regulating gene expression patterns
Downstream of Pyk2, we sought to identify transcription factors that might be
responsible for regulating gene expression in response to changes in cell adhesion. We
used CARRIE analysis, which identifies from microarray data both transcription factors
that change expression in response to a stimulus and those whose binding sites are overrepresented in the promoter regions of the group of genes responding to the stimulus
(Haverty et al., 2004). We identified several transcription factors, including STAT5 (A
and B), heat shock factor 1 and 2, hepatic nuclear factor 1, and cMyc/Max (Fig. 3.9), that
may be important in regulating gene expression responses to changes in cell adhesion and
VEGF exposure.

While we have not yet investigated these factors in depth,

JAK/STAT5A has been shown to be activated by integrin-mediated cell adhesion (Brizzi
et al., 1999) and VEGF (Dudley et al., 2005) in endothelial cells and so could be an
important regulator of gene expression in our system.
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Figure 3.9.

Transcription factors identified by CARRIE analysis as potential

regulators of adhesion-sensitive genes.

Lists of transcription factors identified by

CARRIE analysis as potential regulators of gene expression changes between spread and
unspread cells with and without VEGF stimulation. Lists represent top 10 transcription
factors identified by ROVER analysis, with accompanying ROVER p-value.

70

3.4 Discussion
The roles of Pyk2 versus FAK in angiogenesis
Previous studies have suggested that FAK and Pyk2 have overlapping and
redundant functions in regulating angiogenesis. While the endothelial-specific FAK
knockout is embryonic lethal (Braren et al., 2006; Shen et al., 2005), conditional
knockout in adults results in no abnormal phenotype due to a compensatory mechanism
in which Pyk2 upregulation rescues angiogenesis (Weis et al., 2008). Interestingly, while
Pyk2-null mice have no overt developmental vascular defects, hindlimb reperfusion after
ischemia is impaired, and Pyk2-null endothelial cell migration and tubulogenesis are
defective (Matsui et al., 2007). The importance of Pyk2 only in adult angiogenesis could
be explained by its lack of expression in embryonic endothelium (Avraham et al., 1995),
whereas FAK is always expressed.

Our results indicate FAK and Pyk2 may be

responsible for different aspects of angiogenesis depending on the adhesive context. We
show that Pyk2 activity is upregulated with decreased adhesion and that it is responsible
for promoting angiogenic gene expression and sprouting in limited adhesive contexts. In
contrast, FAK activity is increased with greater cell adhesion and spreading (Guan et al.,
1991; Pirone et al., 2006), has little effect on modulating the expression of angiogenic
genes associated with endothelial invasion and migration, but appears to be important for
regulating endothelial cell proliferation (Gilmore and Romer, 1996; Pirone et al., 2006).
Thus, FAK and Pyk2 may be responsible for differences in the regulation and character
of angiogenesis in developmental versus adult settings as well as in high versus low
density matrices. This balance between the two homologues may even explain observed
differences in endothelial cell behaviors within a single angiogenic sprout as a result of
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local gradients in the adhesive cues present, in which cells in the stalk are surrounded by
a more developed ECM and proliferate while cells at the tip are degrading ECM and
taking on a more invasive phenotype (Fig. 3.10).

Figure 3.10. Proposed model of adhesive regulation of angiogenesis mediated by
Pyk2 and FAK. In relatively low adhesion contexts, Pyk2 activity is high, promoting
sprouting and expression of genes associated with an invasive angiogenic phenotype in
response to VEGF. In contrast, FAK activity is high in relatively high adhesion contexts,
promoting cell survival and proliferation, as well as vascular stability.
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Although FAK and Pyk2 are homologues with some structural and sequence
similarity, they have distinct characteristics that could explain their individual functions
in the context of angiogenesis. The increase in Pyk2 activity with decreased adhesion
could potentially result from a direct competition with binding partners of FAK.
Adhesion is thought to increase FAK signaling in part by co-localizing FAK signaling
partners to assembling focal adhesions (Parsons, 2003). Pyk2, with its more cytoplasmic
distribution as compared to FAK (Zheng et al., 1998), may therefore better access
upstream and downstream signaling partners when they are not sequestered into focal
adhesions. Elucidating how the activation of Pyk2 then regulates invasive angiogenic
genes while FAK regulates proliferative genes is an important direction for future studies.
Here, we report a role for limited endothelial adhesion in promoting an invasive
angiogenic gene expression profile and capillary sprouting, and demonstrate that Pyk2
plays a critical role in mediating these effects.

These findings further suggest the

existence of a balance between invasive and proliferative phenotypes regulated by cell
adhesion, which is potentially mediated by a balance between Pyk2 and FAK signaling.
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CHAPTER 4
REGULATION OF ANGIOGENESIS BY TUNABLE
POLY(ETHYLENE GLYCOL) HYDROGELS

4.1 Introduction
A major goal of understanding how the ECM regulates angiogenesis is to apply
this knowledge toward engineering materials to promote vascularization for tissue
engineering and therapeutic angiogenesis. Synthetic materials including hydrogels have
been instrumental in furthering this goal given their biocompatibility and nonimmunogenicity, as well as more control over material parameters such as compliance,
adhesive ligand density and type, and porosity (Lutolf and Hubbell, 2005).
PEG hydrogels are widely used in tissue engineering applications and serve as a
simple platform onto which various biological functionalities can be incorporated to
mimic the native cellular microenvironment.

PEG itself resists protein adsorption

(Gombotz et al., 1991), so cells can only interact with it through covalently crosslinked
oligopeptides such as RGD that represent integrin binding regions within native ECM
proteins (Hern and Hubbell, 1998). MMP-sensitive sequences can also be incorporated
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into the PEG backbone to render the material degradable by cellular proteases (Lutolf et
al., 2003a; Lutolf et al., 2003b; Mann et al., 2001a). The mechanical properties of PEG
hydrogels can be varied through either crosslinking density or chain length between
crosslinks. All of these properties are significant given the importance of adhesive ligand
density and type, MMP degradation, and mechanical compliance on angiogenesis.
Further, the modular synthetic scheme allows us to begin to explore the roles of
individual parameters in angiogenesis independent of others.
While most studies of angiogenesis are undertaken in native ECMs such as fibrin,
collagen, or Matrigel, several recent studies have made use of PEG hydrogels and their
versatile chemical modifications. PEG hydrogels containing covalently immobilized
VEGF (Leslie-Barbick et al., 2009) and VEGF released by cell-mediated proteolytic
degradation (Zisch et al., 2003) demonstrated enhanced endothelial tubulogenesis and
vascular invasion. Covalent incorporation of ephrin A1, a cell-cell adhesion molecule
important in regulating vascular guidance and assembly, promoted endothelial cell
adhesion and tubule formation (Moon et al., 2007), and immobilizing the cell-adhesive
peptide RGDS in patterns of lines on the surface of PEG hydrogels identified an
intermediate width ideal for formation of endothelial cords (Moon et al., 2009),
consistent with previous results demonstrating enhanced tubulogenesis on fibronectin
lines of intermediate width (Dike et al., 1999; Ingber and Folkman, 1989).
In this chapter, we began to explore ECM parameters promoting optimal
vascularization, including degradability, adhesive ligand density, and mechanical
compliance, using PEG hydrogels. We also made use of our ability to vary parameters
independently in these hydrogels to study the interaction between mechanical compliance
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and adhesive ligand density in regulating angiogenesis. For these studies, we used the
step-growth polymerization of bis-cysteine MMP-sensitive peptides and PEG-diacrylate
(PEGDA) or PEG-diacrylamide (PEGDAAm) to make high molecular weight
photoactive macromers.

These macromers were then crosslinked along with cell-

adhesive acrylate-PEG-CRGDS into hydrogels during a second radical-mediated
photopolymerization step.

Resultant hydrogels were characterized for MMP

susceptibility, cell adhesion, and mechanical compliance and then assessed for
angiogenic potential with an ex vivo chick aortic arch assay.

4.2 Materials and Methods
4.2.1 Reagents and cell culture
All reagents were from Sigma-Aldrich (St. Louis, MO) and were used as received unless
otherwise described. Acryloyl chloride was from Alfa Aesar (Ward Hill, MA). Culture
media and human umbilical vein endothelial cells (HUVECs) were from Lonza (Basel,
Switzerland), and were maintained in complete Endothelial Growth Medium-2 (EGM-2,
Lonza).
4.2.2 Synthesis and characterization of poly(ethylene glycol) diacrylate (PEGDA)
Dry poly(ethylene glycol) (PEG; molecular weight (MW) 3400 or 6000) was acrylated by
reaction with triethylamine (TEA; clear, colorless, 2 molar excess to PEG) and acryloyl
chloride (clear, colorless, 4 molar excess to PEG) in anhydrous dichloromethane (DCM)
under argon as described previously (Mann et al., 2001a). Yields were typically in the
range 80-90% (~120 g), and percent acrylation was 99% as verified by 1H NMR for the
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characteristic peak (4.32 ppm) of the PEG methylene protons adjacent to the acrylate
(Mann et al., 2001a).
4.2.3 Synthesis
(PEGDAAm)

and

characterization

of

poly(ethylene

glycol)

diacrylamide

PEGDAAm was synthesized similar to a protocol described previously (Gobin and West,
2002; Mann et al., 2001a; West and Hubbell, 1999) by taking PEG through a dimesylate,
and then a diamine, before arriving at the diacrylamide. To a solution of dry PEG (MW
3400, 140 g, 0.0412 mol) and 4-dimethylaminopyridine (DMAP, 0.1 molar equivalent to
mesyl chloride, .0247 moles, 3.0183 g) in anhydrous dichloromethane (DCM, 150 mL)
under argon was added anhydrous triethylamine (TEA, 6 molar excess to PEG, 34.4 mL,
0.2471 mol). After mixing for 10 minutes, a concentrated solution of mesyl chloride
(MsCl, 6 molar excess to PEG, 19.1 mL, 0.2471 mol) in DCM was added dropwise with
rapid stirring. The reaction proceeded overnight under argon. PEG dimesylate was
purified by filtering the solution through filter paper under vacuum, followed by
precipitation in diethyl ether (1 L). The product was again filtered and dried under
vacuum to yield PEG dimesylate. To synthesize PEG diamine from PEG dimesylate, the
entire PEG dimesylate product was added to 800 mL 25% aqueous ammonia solution
within 2 days of completing the previous reaction. The container was closed and sealed
tightly with Parafilm, and the reaction proceeded for 4 days with vigorous stirring at
room temperature. The container was then opened to atmosphere to allow the ammonia to
evaporate over 3 days. To remove remaining ammonia, NaOH was used to raise the pH
of the solution to 13, and the solution was extracted with DCM (1:5 DCM volume to
ammonia solution) 3 times. The DCM washes were pooled and concentrated under rotary
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evaporation. The product was then precipitated in diethyl ether, filtered, and dried under
vacuum. Yields were typically ~80%, and percent amination was 99% as verified by 1H
NMR for the characteristic peak (3.1 ppm) of the PEG methylene protons adjacent to the
amine end group. To synthesize PEG diacrylamide from PEG diamine, anhydrous DCM
(75 mL) was added to PEG diamine (70 g, .0206 mol) and stirred until the solution
became clear. The mixture was cooled to 4 ºC on ice. To this cooled solution was added
diisopropylethylamine (DIPEA, 2 molar excess to PEG diamine, 5.7 mL, .0412 mol),
followed by acryloyl chloride (4 molar excess to PEG diamine, 6.5 mL, 0.083 mol)
dropwise with rapid stirring. The reaction proceeded overnight under argon protected
from light and allowed to warm to room temperature. Aqueous reaction byproducts were
removed by using aqueous 2M K2CO3 (2 molar excess to acryloyl chloride, 82.4 mL,
0.164 mol) to phase separate the solution overnight. The lower organic phase was dried
over MgSO4 to remove residual aqueous solution, filtered, precipitated in diethyl ether,
and dried under vacuum to yield PEG diacrylamide. Yields were typically ~70%, and
percent amidation was >90% as verified by 1H NMR for the characteristic peaks (5.6, 6.1,
and 6.3 ppm) of the vinyl protons on the acrylamide end groups.
4.2.4 Synthesis of MMP-sensitive acrylate-PEG-(peptide-PEG)m-acrylate conjugates
The bis-cysteine peptide sequences CGPQGIWGQGCR (highly degradable, HD, 1261.42
g/mol),

CGPQGIAGQGCR

(native

collagen,

NC,

1146.28

g/mol),

and

CGPQGPAGQGCR (least degradable, LD, 1130.23 g/mol) were custom synthesized by
Aapptec (Louisville, KY). Each peptide was supplied as a trifluoroacetate salt at >95%
purity. Peptides were evacuated of air and stored under argon (to minimize disulfide
formation) at -80 ºC until needed. In a typical reaction, 183.8 µmol bis-cysteine peptide
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(HD, 231.6 mg) was reacted with a 1.6 molar excess of PEGDA (MW 3400, 1 g, 294.1
µmol) or PEGDAAm (MW 3400, 1 g, 294.1 µmol) by dissolution in 10 mL 100 mM
sodium phosphate, pH 8.0 (94.7 mM Na2HPO4, 5.3 mM NaH2PO4). The reaction was
sterile filtered through a 0.22 µm PVDF membrane (Millipore, Billerica, MA), protected
from light and proceeded on a circular shaker for 85 hr at room temperature to yield
acrylate-PEG-(peptide-PEG)m-acrylate or acrylamide-PEG-(peptide-PEG)m-acrylamide
conjugates. The reaction mixture was dialyzed against 4 L 18 MΩ water (Millipore) with
pre-swollen regenerated cellulose dialysis tubing (MWCO 3500, “snake-skin”, Pierce,
Rockford, IL) for 24 hours (4 water changes). The dialyzed PEG-peptide conjugates were
frozen overnight (-20 ºC), lyophilized, and stored at -80 ºC until use.
4.2.5 Characterization of PEG-peptide macromers by GPC
PEG-peptide conjugates were analyzed by GPC with a refractive index detector and DMF
solvent using three tandem styrene-divinylbenzene (SDVB) columns spanning a linear
MW range from 1 kDa to 500 kDa for polystyrene. PEG MW standards from 628 Da to
478 kDa (Sigma) were used for assessment of the molecular weight of the PEG-peptide
conjugates.
4.2.6 PEG-peptide macromer photopolymerization to form hydrogels
PEGDA, PEGDAAm, or PEG-peptide macromers were individually dissolved at 6-20%
w/w concentration in PBS to make stock prepolymer solutions at the beginning of each
experiment. The desired amounts of cell-adhesive and MMP-sensitive macromers were
then mixed and diluted to the proper experimental concentration with PBS. To maintain
concentration accuracy during dissolution, it was noted that PBS volume increased upon
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addition of PEG-peptide conjugates by approximately 0.9 µL/mg added. All macromers
are reported as their initial concentration during hydrogel polymerization. A solution (100
mg/mL in 100% ethanol) of the photoinitiator Irgacure 2959 (I2959, Ciba, Tarrytown,
NY) was added to a final working concentration of 0.05% w/v (by using 5 µL of the
initiator solution per 1 mL hydrogel prepolymer solution). Solutions were thoroughly
mixed and sonicated before polymerization. The prepolymer solution was transferred into
plastic molds (96-well plate) for degradation assays, between glass plates for the
modified Lowry assay, or dispensed onto a sterile slab of poly(dimethyl siloxane)
(PDMS;

Dow

Corning)

for

explant

encapsulation

as

described

below.

Photopolymerization was conducted with an Omnicure S2000 (320-500 nm, EXFO,
Ontario, Canada) lamp at 100 mW/cm2 (measured for 365 nm) to yield solid hydrogels
(exposure times reported in relevant sections below). Hydrogels containing explants were
easily transferred into culture media with flat, round tip tweezers (EMS, Switzerland).
4.2.7 Collagenase (MMP-1) degradation assay
A collagenase degradation assay was employed to check the MMP-sensitivity of these
hydrogels and their relative degradation behavior, in a similar fashion as described
previously (Mann et al., 2001a). Briefly, hydrogel prepolymer solutions were made in
HEPES-buffered saline (HBS; 10 mM, pH 7.4) containing 0.2 mg/mL sodium azide (to
inhibit microbial growth), mixed with initiator, and polymerized for 60 seconds as
described above. Hydrogels (150 µL starting volume per gel) were swollen for 36 hr at
37 ºC and weighed to assess equilibrium swollen weight. These swollen hydrogels were
then transferred to a 0.2 mg/mL collagenase 1 (MMP-1) solution (made with the same
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buffer), and their wet weight was monitored over time (3 gels per condition). Control
hydrogels were incubated in buffer without enzyme.
4.2.8 Synthesis and characterization of cell-adhesive acrylate-PEG-peptide conjugates
Cell adhesive or non-adhesive acrylate-PEG-peptide conjugates were prepared in a
similar manner to the MMP-sensitive conjugates by using a 1.0 molar equivalent of
PEGDA (MW 3400) for the monocysteine peptides CGRGDS (adhesive, 593.59 g/mol)
and CGRGES (non-adhesive, 607.62 g/mol). These conjugates were characterized by
GPC as described above.
4.2.9 Characterization of the immobilization stability of cell-adhesive acrylate-PEGpeptide conjugates
To verify the immobilization stability of acrylate-PEG-RGDS in PEG gels we developed
a modified Lowry Assay (Sigma) in prepolymer solutions or in solid hydrogels to
quantify peptide concentration in situ. For solutions, acrylate-PEG-CGRGDS solutions
were made in sterile water (the Lowry assay is not reliable in PBS) and assessed as
described below with the free peptide CGREDV used as a standard. For solid hydrogels,
10% w/w PEGDA 6000 hydrogel prepolymer solutions were made containing 0, 0.25, 2,
or 4 µmol/mL acrylate-PEG-CGRGDS. Initiator was added as described above, then each
solution was transferred to a glass chamber composed of thin rubber spacers sandwiched
between two glass slides (chamber dimensions: 30 mm x 40 mm x 0.48 mm thick).
Hydrogels were polymerized for 120 seconds (25 mW/cm2) and then sliced into 3
sections to yield hydrogels approximately 7 mm x 15 mm x 0.48 mm. Gels were
subjected to a modified Lowry assay immediately after polymerization, or after a 24 hour
or 72 hour incubation at 37 ºC in sterile water (changed daily). At these specified times,
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hydrogels were blotted dry with laboratory wipes, then placed in a test tube with 1 mL
deionized water. While vigorously mixing, 1 mL Lowry reagent was added according to
the vendor's recommendations. Mixing continued for 40 seconds and hydrogels were left
at room temperature for 20 minutes. While vigorously mixing, 0.5 mL Folin-Ciocalteu's
phenol reagent was added. Mixing continued for 40 seconds and hydrogels were left at
room temperature for 30 minutes. Hydrogels were blotted dry, transferred to plastic
cuvettes and assessed with a UV/Vis spectrophotometer (750 nm) transverse to the wide
hydrogel face. Absorbance values were normalized to PEGDA gels without peptide.
4.2.10 Characterization of cell attachment to adhesive acrylate-PEG-peptide conjugates
Cell-adhesive 20% w/w PEGDA 3400 hydrogels were formed containing 4 µmol/mL
acrylate-PEG-CGRGDS or acrylate-PEG-CGRGES in PBS and swollen for 24 hours at
37 ºC. Hydrogels were briefly rinsed with media, then seeded with HUVECs (15,000
cells/cm2). Hydrogels were rinsed with PBS after 24 hours and photographed to check
cellular attachment.
4.2.11 Mechanical testing
The shear modulus of PEG gels was obtained using an AR 2000 oscillating rheometer
(TA Instruments) with a 20 mm stainless steel parallel plate. For measurements taken
during gel polymerization, the head was lowered onto 140 µL of unpolymerized gel
solution to a gap of 448 µm such that gel filled the entire cylindrical volume between the
plates. Measurements were taken at a frequency of 1 Hz and strain of 1% during
photopolymerization using an Omnicure S2000 (320-500 nm, EXFO, Ontario, Canada)
lamp at 100 mW/cm2 (measured for 365 nm), with values reported at 30 seconds of UV
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exposure. Measurements of pre-swollen gels were taken on a temperature-controlled
Peltier plate at 37ºC. Cylindrical gel samples were created from 125 μL of precursor
solution, covalently linked to 3-(trimethoxysilyl)propyl methacrylate (Sigma)-treated
glass microscope slides and then swollen in PBS for 36 hours. Immediately prior to
testing, the slides were removed from media and carefully blotted dry with laboratory
wipes. The heights and diameter of the swollen gels were measured with calipers and
were typically ~1 mm thick and ~19 mm in diameter. The head was lowered to a gap
corresponding to 10-20% axial compression of the samples. Measurements were taken at
a frequency of 1 Hz and strain of 1%.
4.2.12 Chick aortic arch explant angiogenesis assay
Chick aortas were isolated from 12-day-old chick embryos (Charles River Labs, Preston,
CT). Aortic arches were cleaned of excess fibroadipose tissue, sectioned into ~0.5 mm
sized rings, and submerged inside a 30 µL droplet of hydrogel prepolymer solution.
Polymerization was performed for 30 seconds as described above, and culture media
(EGM-2; 0.75 mL per hydrogel) was changed on day 1 and every 3 days thereafter.
Hydrogels were photographed daily with oblique lighting phase contrast microscopy to
optically exclude 2D cell migration on the surface of hydrogels and instead visualize only
those cells which migrated in 3D within the hydrogels. Sprout area was assessed by
image thresholding and edge-finding filters (Matlab), 2 sides per ring, 4-6 rings per
experimental group. Statistics were assessed by one-way ANOVA with Tukey’s HSD
post-hoc testing, and p-values less than 0.05 were considered significant. For endothelial
cell labeling experiments, aortic arch explants were incubated with rhodamine-lectin
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(Lens culinaris agglutinin, 20 μg/ml, Vector Laboratories) for 1.5 hours before
encapsulation in hydrogels.

4.3 Results
4.3.1 Material design and analysis
To develop a PEG hydrogel system in which degradable and adhesive
components are incorporated using simple chemistries, we first employed the step-growth
polymerization of PEGDA or PEGDAAm with MMP-sensitive peptides. The resulting
high molecular weight photoactive macromers could then be crosslinked along with celladhesive PEG conjugates into hydrogels by photopolymerization (Fig. 4.1A, 4.2A). We
started with the synthesis of PEGDA or PEGDAAm (Fig. 4.1A,B), as previously
described (Gobin and West, 2002; Mann et al., 2001a; West and Hubbell, 1999). While
initial studies used PEGDA given its easy synthesis and rapid reaction with thiol-bearing
peptides, PEGDAAm was ultimately preferred for long-term tissue explant studies given
the stability of the amide bond in PEGDAAm compared to the hydrolytically unstable
ester bond in PEGDA.
MMP-sensitive peptides were flanked with leading and lagging cysteine residues
to react with terminal acrylates and acrylamides on PEGDA and PEGDAAm via
Michael-type addition. Since PEG is linear, step-growth polymerization of bis-cysteine
peptides with PEGDA or PEGDAAm did not result in hydrogel formation directly but led
to macromer chain extension such that multiple MMP-sensitive peptides were
incorporated into each polymer chain. These extended chains could then be crosslinked
into hydrogels by photopolymerization using unreacted terminal acrylate and acrylamide
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groups.

MMP-sensitive peptide sequences were selected to cover a range of

degradabilities based on previous studies (Imper and Van Wart, 1998; Lee et al., 2005;
Lutolf et al., 2003a): highly degradable (“HD”), collagen native (“CN”), and least
degradable (“LD”) (Fig. 4.1A).
Step-growth polymerization is strongly controlled by the stoichiometric ratio of
the reactants. In order to ensure that acrylates remained at the terminal ends of MMPsensitive macromers (to enable later photopolymerization), an excess of PEGDA or
PEGDAAm compared to peptide was used. With a PEGDA:peptide molar ratio of 1.6,
more than 90% of the PEGDA reacted with peptide (sum of “high” and “medium”
molecular weights in Fig. 4.2B), indicating successful Michael-type addition.
Surprisingly, approximately 60% of the resultant molecular species were greater than 500
kDa. Unreacted MMP-sensitive peptide was not observed by GPC, either due to the
completeness of the reaction or from being washed away during dialysis. Importantly, all
three MMP-sensitive peptides showed nearly identical polydispersity, indicating that
Michael-type addition proceeded similarly for each peptide sequence. Reacted species are
of the form acrylate-PEG-(peptide-PEG)m-acrylate, and for a macromer molecular weight
of 500 kDa, the m-value is approximately 100. PEGDAAm reacted with peptide at a
molar ratio of 1.6 demonstrated a similar profile, with 85% of the PEGDAAm reacted
with peptide and approximately 45% greater than 500 kDa (data not shown). Here,
reacted species are of the form acrylamide-PEG-(peptide-PEG)m-acrylamide.
To make pendant cell-adhesive RGDS peptide, we reacted CGRGDS peptide with
PEGDA at a PEG:peptide ratio of 1.0. GPC analysis showed that 87% of the PEGDA
reacted with peptide. The lack of a second cysteine residue on this peptide prevents step85

growth polymerization and thus the possibility of high molecular weight macromers.
However, double conjugation in the form peptide-PEG-peptide is possible in this
reaction. Of the peptide-conjugated PEGDA, 63% was in the preferred acrylate-PEGCGRGDS form. These data suggested sufficient coupling of peptide for their covalent
incorporation into hydrogels as cell-adhesive pendant chains.
This design strategy builds on components from previously described PEG
systems:

Michael-type addition to couple thiol-bearing peptides to acrylate and

acrylamide groups on PEG as employed by Hubbell and colleagues (Elbert and Hubbell,
2001; Lutolf et al., 2003a; Lutolf et al., 2003b) and photopolymerization of acrylated
PEG derivatives into hydrogels similar to West and colleagues (Gobin and West, 2002;
Mann et al., 2001a; West and Hubbell, 1999). This strategy is attractive because it
employs simple chemistries and starting reagents—avoiding costly and limited reagents
such as heterobifunctional or multi-arm PEGs—while preserving the ability to
photopolymerize and spatially pattern hydrogels.
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Figure 4.1. Synthesis of PEGDA, PEGDAAm, and cell-adhesive and MMP-sensitive
conjugates.

(A) Scheme for synthesizing cell-adhesive or MMP-sensitive PEG

conjugates from PEGDA. PEG is reacted with acryloyl chloride to form PEGDA, which
is then reacted with cysteine-bearing peptides via Michael-type addition to form celladhesive or, in a separate reaction, MMP-sensitive PEG–acrylate macromers.

(B)

Synthesis of PEGDAAm, which is also used to form cell-adhesive and MMP-sensitive
conjugates as in (A), but with more stable amide bonds replacing ester bonds. PEG is
reacted with methanesulfonyl chloride to form PEG dimesylate, which is reacted with
aqueous ammonia to form PEG diamine. PEG diamine is reacted with acryloyl chloride
to form PEGDAAm.
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Figure 4.2.

Hydrogel structure schematic and GPC analysis of MMP-sensitive

macromers. (A) Schematic illustration of hydrogel structure. Photopolymerization of
the photoactive precursors from Fig. 4.1 yields bioactive hydrogels with multiple MMPsensitive peptides per backbone chain and pendant cell-adhesive ligands tethered from
sites of acrylate crosslinking. (B) GPC analysis of MMP-sensitive PEG-diacrylates
plotted against PEG MW standards. Reaction of MMP-sensitive peptides with a 1.6
molar excess of PEGDA via step-growth polymerization resulted in more than 90%
conjugation (sum of medium and high MWs), with a majority of the molecular weight
species greater than 500 kDa. Highly degradable (‘‘HD’’), collagen native (‘‘CN’’), and
least degradable (‘‘LD’’) PEG–peptide conjugates show nearly identical polydispersity.
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4.3.2 Degradable peptide sequences regulate angiogenic sprouting
We first tested whether incorporation of specific MMP-sensitive peptide
sequences rendering hydrogels more or less degradable could regulate angiogenic
sprouting in these gels, as angiogenesis is known to be regulated by the interplay of cellsecreted MMPs with the extracellular matrix (Chun et al., 2004; Ghajar et al., 2008b).
Sequences were chosen to be derived from the native collagen sequence (CN) or
substantially more (HD) or less (LD) degradable by MMPs. Relative to the CN peptide,
the HD peptide is 840%, 310%, and 240% more degradable by MMP-1, MMP-2, and
MMP-9, respectively (Imper and Van Wart, 1998). In contrast, the LD peptide is 0.5%,
5%, and 5% less degradable by those MMPs. To characterize degradation profiles of the
hydrogels, hydrogels were allowed to reach equilibrium swelling in aqueous buffer and
then degraded in collagenase 1 (MMP-1) solution while their wet weight was monitored.
Hydrogels swelled dramatically in aqueous buffer (Fig. 4.3A), a result of the long chain
lengths of the macromer precursors. This substantial swelling, along with the presence of
multiple MMP-sensitive peptides within each macromer chain, likely contributed to the
rapid degradation of the gels as compared to other similar MMP-sensitive hydrogels
(Gobin and West, 2002; Mann et al., 2001a; West and Hubbell, 1999). The observed
degradation profiles differed substantially from the reported degradabilities of the
peptides in soluble form: hydrogels containing HD and CN peptides had very similar
profiles, while LD hydrogels required only twice the amount of time to degrade fully
(Fig. 4.3B). These discrepancies can be attributed at least in part to the presence of
multiple degradable peptides along each macromer chain such that cleavage of only one
peptide cleaves the entire chain, as well as to the concentration of collagenase used
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(selected to be consistent with the literature but perhaps too high to be sensitive to
sequence differences).
To study angiogenic sprouting in hydrogels of varying degradabilities, we used
the chick aortic arch assay described in Chapter 2. The three MMP-degradable sequences
were incorporated in hydrogels to vary only MMP susceptibility, while holding polymer
weight percent and adhesive peptide concentration constant.

Significantly more

angiogenic sprouting was observed in HD hydrogels over 4 days, with CN hydrogels
exhibiting intermediate sprouting and LD hydrogels minimal sprouting, as measured by
area of sprouting from explants (Fig. 4.4A,B). Moreover, angiogenic sprouting was
completely suppressed to undetectable levels by substitution of CGRGDS with the nonadhesive CGRGES peptide, confirming that the hydrogels support angiogenic invasion
only in the presence of an adhesive peptide. We verified that endothelial cells were a
principal component of the observed explant sprouts by labeling the chick arches with an
endothelial-specific lectin (Fig. 4.4C). These results demonstrate the importance of
MMP susceptibility in regulating sprouting angiogenesis, as well as our ability to control
the angiogenic response by incorporation of specific bioactive peptide sequences in PEG
hydrogels.

90

Figure 4.3. Characterization of hydrogel swelling and degradation in collagenase.
(A) MMP-sensitive hydrogels (made from HD, CN, or LD peptides) were polymerized at
10% w/w and then swollen to equilibrium over 36 hrs. Graph shows average of three
samples, ± standard deviation.

(B) Swollen hydrogels were degraded in 0.2 mg/mL

collagenase (n = 3) or incubated in buffer (n = 1) up to 8 hrs while their wet weight was
monitored. Note that HD and CN have overlapping degradation curves. Bars indicate
standard deviation.
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Figure 4.4.

MMP sensitivity of hydrogels regulates ex vivo sprouting.

(A)

Representative images of chick aortic ring explants sprouting into hydrogels over time.
In 8-wt% gels with 1.0 μmol/mL CGRGDS density, angiogenic sprouting varies with the
MMP-susceptibility of the hydrogel backbone. No detectable sprouting occurred in
negative control hydrogels containing RGES instead of RGDS peptide. Scale bar for all
images = 250 μm. (B) Quantification of sprout area at day 4, n = 6 per condition. Graph
shows means with standard deviation, all comparisons are significant, p < 0.003 by oneway ANOVA and Tukey’s HSD post-hoc test. (C) Fluorescent staining with rhodaminelabeled lectin implicates endothelial cells as a principal component of the angiogenic
sprouts in these hydrogels. Scale bar = 100 μm.
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4.3.3 Interaction between adhesive ligand density and mechanical compliance in
regulating angiogenic sprouting
While the roles of cell-ECM adhesion and ECM compliance in angiogenesis have
independently been studied with tremendous interest (reviewed in Chapter 1), the
interplay between the two has not yet been investigated, primarily because of the
difficulty of segregating their effects in traditional 3D material systems.

Varying

collagen, fibrin, or Matrigel density varies not only adhesive ligand density but also ECM
stiffness (Duong et al., 2009; Paszek et al., 2005; Zaman et al., 2006), although studies
have employed chemical crosslinking of these native ECMs to increase matrix stiffness
while keeping ligand density constant (Kuzuya et al., 1998; Standeven et al., 2007) or
added exogenous adhesive ligand to vary ligand density while keeping stiffness constant
(Zaman et al., 2006). In this latter study, tumor cell migration in 3D Matrigel matrices
was found to be regulated by a complex interaction between ligand density, stiffness, and
MMP proteolytic activity. A biphasic response to changes in integrin-adhesive ligand
binding was observed, similar to previous studies on 2D surfaces (Palecek et al., 1997;
Wu et al., 1994). A biphasic response to changes in compliance was also observed, and
the authors suggested a shift in optimal adhesive ligand density with changes in
compliance (i.e. lower density with increased compliance) such that contractile force and
adhesiveness were in balance, as predicted by a model (Zaman et al., 2005). Using
artificial 3D matrices, independent variation of adhesive ligand density has demonstrated
a biphasic effect of ligand density on migration of several cell types, including fibroblasts
and smooth muscle cells (Burgess et al., 2000; Gobin and West, 2002; Lutolf et al.,
2003a; Schense and Hubbell, 2000). Using a 2D polyacrylamide gel system in which
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ligand density and stiffness could be varied independently, the two properties were found
to be coupled in regulating smooth muscle cell spreading: while these cells generally
exhibit a biphasic spreading response to ligand density, cells on softer gels were
relatively insensitive to increasing collagen ligand density and remained round, whereas
cells on stiffer gels demonstrated a robust biphasic increase in spreading in response to
increased ligand density (Engler et al., 2004).
Here, we have begun to study the coordinate regulation of angiogenic sprouting
by adhesive ligand density and matrix stiffness using our PEG hydrogels that allow for
independent variation of these properties. We first verified our ability to immobilize
different amounts of the adhesive RGDS ligand in the hydrogels. To quantify the amount
of RGDS entrapped or immobilized in the hydrogel during polymerization and its
subsequent stability in the hydrogel over time, we developed a modified Lowry Assay for
in situ quantification (Lowry et al., 1951). We confirmed that the assay, which provides
a colorimetric measurement of the total amount of peptide bonds present and is typically
used for large proteins, could be applied to quantify the concentration of short peptides
using the CGREDV peptide as a standard (Fig. 4.5A). When applied to our acrylatePEG-CGRGDS materials diluted in solution, measured peptide concentrations fell within
40-50% of expected values (Fig. 4.5B). We then applied this assay to characterize the
immobilization of CGRGDS in solid hydrogels (Fig. 4.5C). We followed relative peptide
retention in hydrogels over time and observed that hydrogels lost between 30-50% of the
PEGDA-peptide conjugate in the first day of equilibrium swelling, with the remaining
immobilized peptide stable in the gel for several days (Fig. 4.5D). The initial loss of
peptide represented double-conjugated peptide-PEG-peptide from the reaction of PEGDA
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with CGRGDS peptide, which was physically entrapped in the gel at first but diffused
away during equilibrium swelling.

These results are consistent with GPC analysis

indicating 63% of CGRGDS conjugate in the preferred acrylate-PEG-CGRGDS form.
To confirm the bioactive potency of the cell-adhesive conjugate, we measured adhesion
of HUVECs to PEGDA hydrogels containing the cell-adhesive CGRGDS or nonadhesive CGRGES peptide (Fig. 4.5E). While CGRGES peptide was unable to support
HUVEC adhesion, CGRGDS peptide supported robust HUVEC adhesion and cell
spreading. This assay confirmed that sufficient adhesive peptide is immobilized in the
hydrogels to support cell adhesion. In subsequent studies, we varied the concentration of
RGDS peptide in hydrogels to investigate effects on angiogenic sprouting in 3D.
To vary stiffness of the gels, we altered crosslinking density by controlling
polymer weight percent. The shear modulus of both non-swollen PEGDA gels (Fig.
4.6A) and swollen PEGDAAm gels (Fig. 4.6B) increased with increasing weight percent,
with the storage modulus of 4-6 weight percent degradable, swollen PEGDAAm gels
ranging from 100 to 1300 Pa. We did note an increase in modulus with increasing
concentrations of CGRGDS-conjugated PEG (Fig. 4.6A), as predicted by a recent study
(Beamish et al.). This prompted us to incorporate non-adhesive CGRGES peptide along
with CGRGDS in the gels such that the total concentration of monoacrylated, ligandconjugated PEG remained constant for all conditions. Gels containing both CGRGDS
and CGRGES at different ratios but the same total peptide concentration had similar
mechanical properties (Fig. 4.6B), confirming our ability to modulate adhesion and
mechanical compliance independently in these gels.
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Figure 4.5.

Characterization of the immobilization efficiency and stability of

acrylate–PEG–peptide macromers in PEGDA gels. (A) The Lowry assay, typically
only used for large proteins, produced a linear standard curve from the short, soluble
CGREDV peptide, even at low concentrations. (B) This standard curve was used to
quantify the solution-based concentration of acrylate–PEG–CGRGDS and acrylate–
PEG–CGRGES conjugates, with a deviation from expected of 40–50%, with values
comparable between both peptides. Bars indicate standard error. (C) Gross appearance of
hydrogel slabs after modified Lowry assay in situ showing characteristic blue color with
starting peptide concentration (μmol/mL). The linear dependence on concentration was
also valid in solid hydrogels (bars indicate standard deviation). (D) The assay tracked
CGRGDS retention over time within hydrogels. A large percent of RGDS was lost on
the first day during hydrogel equilibrium swelling. The remaining peptide was stable for
at least 2 more days in the gel (n=3 for all samples), with up to 75% retention. Bars
indicate standard deviation. (E) HUVEC morphology on PEGDA hydrogels with 4.0
μmol/mL PEG-CGRGES (left) or PEG–CGRGDS (right) 24 hours post-seeding. Scale
bars = 25 μm.
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Figure 4.6. Rheometry of PEG hydrogels with varying weight percent and RGDS
density. (A) The storage modulus (G’) of 6 and 8 wt-% non-degradable PEGDA gels
containing varying concentrations of RGDS ligand (0-20 μmol/mL), as measured during
photopolymerization. (B) The storage modulus of 4-6 wt-% degradable PEGDAAm gels
containing varying concentrations of RGDS ligand (0-10 μmol/mL) with constant total
ligand density (10 μmol/mL) using non-adhesive RGES ligand. Gels were measured
after 36 hours of equilibrium swelling in buffer.
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We have begun to characterize sprouting from chick aortic rings into PEG gels of
varying adhesive RGDS concentrations and polymer weight percents to study the
interaction between the two in regulating angiogenesis.

In preliminary studies, 3-6

weight percent PEGDAAm gels containing 0, 0.1, 1, and 10 μmol/ml RGDS (total
concentration of RGDS + RGES is 10 μmol/ml for all conditions) were used. All gels
contained the HD degradable peptide sequence. At 3 days after aortic ring encapsulation,
a biphasic response to changes in weight percent was observed, with the greatest amount
of sprouting in 4 weight percent gels (Fig. 4.7-4.11). Interestingly, while sprouting in 3
and 4 weight percent gels exhibited a biphasic response to increased RGDS ligand
density, sprouting in 5 and 6 weight percent gels was relatively insensitive to changes in
ligand density and perhaps even greater with increased ligand density.

Minimal

sprouting was observed in gels containing RGES only. Degradation over time appeared
to alter the properties of the gels, with 3 weight percent gels degraded by 4 days and
sprouting similarly high in 4-6 weight percent gels at day 6. Unexpectedly, we noticed
increased degradation of gels containing lower concentrations of RGDS peptide such that
sprouts in gels containing 0.1 and 1 μmol/ml RGDS began to regress at 4-5 days, while
sprouts in gels containing 10 μmol/ml RGDS continued to grow past 6 days (Fig. 4.11C).
These data, while preliminary, suggest a coupling between adhesive ligand density and
stiffness in regulating angiogenic sprouting. While there was a biphasic response in
sprouting to changes in stiffness at most ligand densities, a biphasic response to changes
in ligand density was observed only in softer gels, with higher ligand densities appearing
to support maximal sprouting in stiffer gels. These results are consistent with our gene
expression data (Figs. 2.5 and 2.7) and previous reports of enhanced angiogenesis at
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intermediate stiffness (Mammoto et al., 2009), as well as with the model of 3D tumor
migration described above (Zaman et al., 2005). A wider range of ligand densities and
stiffnesses will be investigated to study the effects of a full set of physiologically relevant
conditions on angiogenic sprouting, and these same materials will be implanted
subcutaneously in mice to verify these findings in vivo.
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Figure 4.7.

Ex vivo sprouting in degradable PEGDAAm gels is controlled by

stiffness and adhesive ligand density, day 2. Representative images of chick aortic ring
explants sprouting into degradable (HD peptide) PEGDAAm hydrogels of varying wt-%
and RGDS density (with sum of RGDS and non-adhesive RGES constant). Scale bar for
all images = 250 μm.
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Figure 4.8.

Ex vivo sprouting in degradable PEGDAAm gels is controlled by

stiffness and adhesive ligand density, day 3. Representative images of chick aortic ring
explants sprouting into degradable (HD peptide) PEGDAAm hydrogels of varying wt-%
and RGDS density (with sum of RGDS and non-adhesive RGES constant). Scale bar for
all images = 250 μm.
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Figure 4.9.

Ex vivo sprouting in degradable PEGDAAm gels is controlled by

stiffness and adhesive ligand density, day 4. Representative images of chick aortic ring
explants sprouting into degradable (HD peptide) PEGDAAm hydrogels of varying wt-%
and RGDS density (with sum of RGDS and non-adhesive RGES constant). Note 3 wt-%
gels have degraded by this time. Scale bar for all images = 250 μm.
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Figure 4.10. Ex vivo sprouting in degradable PEGDAAm gels is controlled by
stiffness and adhesive ligand density, day 6. Representative images of chick aortic ring
explants sprouting into degradable (HD peptide) PEGDAAm hydrogels of varying wt-%
and RGDS density (with sum of RGDS and non-adhesive RGES constant). Note 3 wt-%
gels have degraded by this time. Scale bar for all images = 250 μm.
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Figure 4.11.

Quantification of ex vivo sprouting in degradable PEGDAAm of

varying stiffness and adhesive ligand density. (A) Quantification of chick aortic ring
sprouting into degradable (HD peptide) PEGDAAm hydrogels as a function of hydrogel
weight percent and RGDS ligand density at days 3 and 6 after encapsulation. (B)
Contour and surface plots showing sprouting as a function of weight percent and RGDS
density at day 3 (interpolation of data). (C) Sprouting in 4 wt-% gels as a function of
RGDS density over 6 days.
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4.4 Discussion
Here we describe an inexpensive, flexible, and readily available route to bioactive
PEG-based hydrogels, which can modulate ex vivo angiogenic sprouting through
chemical control of MMP susceptibility, adhesive ligand density, and mechanical
stiffness. Step-growth polymerization via Michael-type addition was employed to create
high molecular weight bioactive macromers of the form acrylate-PEG-(peptide-PEG)macrylate. These macromers, when photopolymerized along with pendant adhesive ligands
via terminal acrylate groups, resulted in highly hydrated, degradable gels suitable for cell
and tissue encapsulation. 3D angiogenic sprouting from chick aortic rings was controlled
by the MMP susceptibility of the hydrogel backbone, the concentration of adhesive
RGDS peptide, and the mechanical stiffness of the hydrogel. This control allows us not
only to find optimal conditions for sprouting at a given time but also to tune parameters
based on desired time for vascularization and material properties required for other cell
types in a potential engineered tissue construct. The ability to isolate parameters in this
material system also provides an invaluable tool for mechanistic studies of ECM
regulation of angiogenesis.
Work is ongoing to expand the range and combinations of adhesive ligand
density, stiffness, and MMP sensitivity so that we can map angiogenic responses to these
parameters in physiologically relevant ranges. Several of these combinations will be
tested in subcutaneous implants in mice to validate results in vivo. We will also explore
biological mechanisms behind observed responses, including the contribution of
proliferation to sprouting responses and whether differential MMP activity is responsible
for differences in degradation rate in gels of varying RGD density. These studies will
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ultimately provide further insight into ECM regulation of angiogenesis and aid in the
rational design of materials for tissue repair.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS

5.1 Conclusions
The work in this thesis has aimed to further our understanding of the regulation of
angiogenesis by cellular interactions with the ECM, and in particular the role of cellECM adhesion. Previous studies had established a requirement for integrin-mediated
adhesion in angiogenesis (Avraamides et al., 2008; Brooks et al., 1994a; Friedlander et
al., 1995; Kim et al., 2000; Tanjore et al., 2008; Yang et al., 1993), but recent work has
also shown that limiting integrin-mediated adhesion through integrin antagonists can
actually enhance angiogenesis (Reynolds et al., 2009).

Another avenue of inquiry

demonstrated that gradual increases in endothelial cell spreading could regulate a switch
from apoptosis to tubulogenesis to proliferation (Chen et al., 1997; Dike et al., 1999;
Ingber, 1990; Ingber and Folkman, 1989). However, these observations still lacked a
mechanistic basis and a connection to physiological sprouting. Through a combination of
microfabrication tools and native and engineered materials to control the interaction of
endothelial cells with the ECM, our work here has confirmed that quantitative changes in
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adhesion can regulate both the extent and character of angiogenesis. We show that
limited adhesion drives sprouting in part by stimulating an activated endothelial
phenotype associated with vascular invasion and remodeling, which can now be
characterized by a specific gene expression profile. We also implicate Pyk2 in regulating
both limited adhesion-induced gene expression and angiogenic sprouting.

Another

existing challenge in the field is understanding how different components of the ECM
regulate angiogenesis.

While adhesive ligand density, ECM stiffness, porosity, and

degradability are difficult to separate in native ECMs, our synthetic PEG materials have
allowed us to begin to study in a systematic fashion the effects of various ECM properties
on angiogenesis. These hydrogels also support robust vascularization, which has not
been achieved in many synthetic materials, and thus have great potential in tissue
engineering applications.
In Chapter 2, we observed an increase in angiogenic sprouting with decreasing
densities of the native ECM fibrin and used gene expression profiling to probe the
contributions of various ECM properties to this response. We noted an upregulation of
genes associated with an activated angiogenic response—including matrix invasion,
growth factor signaling, and cell-cell and cell-ECM adhesion—in endothelial cells
cultured on small micropatterned islands of fibronectin as compared to fully spread cells.
A similar response was observed in cells cultured on low versus high densities of
fibronectin, implicating limited cell-ECM adhesion as an important driver of angiogenic
gene expression. In investigating the roles of other microenvironmental properties that
could regulate angiogenic sprouting, we observed increased angiogenic gene expression
in cells cultured on soft versus stiff substrates, as well as in cells with reduced cell-cell
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contact. Altogether, these results suggest a role for limited cell-ECM adhesion and
mechanics in promoting angiogenesis, as well as a complex interplay between cell-ECM
and cell-cell interactions that could explain differences in behavior along a single
angiogenic sprout or within different tissue contexts.
In Chapter 3, we investigated a mechanistic basis for the increased angiogenesis
observed with limited cell-ECM adhesion. We screened inhibitors of several molecules
that are known to transduce adhesion signaling, including ERK, ROCK, Src family
kinases, FAK, and the FAK relative Pyk2.

While ERK and ROCK inhibition had

minimal effect on angiogenic gene expression, Src family kinase, FAK, and Pyk2
inhibition decreased gene expression. We focused on FAK and Pyk2 and found, through
more specific molecular manipulations, that Pyk2, but not FAK, is responsible for
increased gene expression in less adherent cells.

Pyk2 inhibition also decreased

sprouting from endothelial spheroids and aortic arch explants, confirming its importance
in functional angiogenesis assays.

Further downstream, we looked for potential

transcriptional regulators of the gene expression profiles observed through CARRIE
analysis and identified several transcription factors that could be responsible for gene
expression changes resulting from alterations in cell-ECM adhesion.
In Chapter 4, we developed an adhesive, degradable PEG-based hydrogel that
supports 3D angiogenic sprouting from aortic arch explants. These wholly synthetic
materials allow for more precise control over ECM properties such as compliance,
adhesive ligand density and type, and degradability. We first demonstrated that specific
MMP-sensitive peptides rendering the hydrogels more or less degradable could control
the degree of angiogenic sprouting. We then examined the interplay between adhesive
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ligand density and mechanical stiffness in regulating angiogenesis.

Through these

multiple tunable parameters, this material can not only be used for vascularizing
engineered implants but also as a platform to study how ECM properties regulate
angiogenesis independent of others.

5.2 Future Directions
5.2.1 Understanding the physiological importance of the adhesive and mechanical
regulation of angiogenesis
Our studies and previous reports (Chen et al., 1997; Dike et al., 1999; Ingber and
Folkman, 1989) suggest that the degree of cell-ECM adhesion and ECM mechanics can
regulate not only the overall amount of sprouting but also a switch between distinct
endothelial cell behaviors important for angiogenesis, such as proliferation versus
invasion and capillary morphogenesis.

In what physiological contexts might these

observations be relevant? It is possible that changes in cell-ECM interaction along a
single angiogenic sprout could be responsible for the diverse behaviors observed.
Enhanced MMP production and ECM degradation at the sprouting tips (Yana et al.,
2007) could decrease adhesion and thereby promote migration and cellular invasion, and
increased ECM deposition along the stalks could be responsible for the observed
proliferation in these regions (Gerhardt et al., 2003). Notably, our microarray analysis
identified upregulation of genes associated with tip cells—VEGFR-2/KDR, PDGF-B,
and MT1-MMP/MMP14 (Gerhardt et al., 2003; Yana et al., 2007)—in cells with limited
adhesion exposed to VEGF, suggesting that adhesive gradients may indeed play an
important role in dictating cellular behavior along angiogenic sprouts. To investigate this
possibility, it would be interesting to localize regions of high ECM degradation and
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deposition along angiogenic sprouts via high-resolution imaging and see if these spatial
patterns correlate with those of endothelial functions. While proliferation has already
been shown to be higher in stalks (Gerhardt et al., 2003), we have not yet explored
whether the genes we identified as associated with an activated angiogenic phenotype are
differentially expressed along angiogenic sprouts. In situ labeling (similar to (Raj et al.,
2008) to determine spatial expression patterns would be instrumental to understanding
how diverse behaviors might be coordinated along sprouts, as well as identify potential
markers that could be used to visualize endothelial phenotypes besides proliferation.
Additionally, our lab has recently developed a method to measure cellular forces in 3D
(Legant et al., submitted). Using this tool, we can potentially measure forces exerted by
cells along an angiogenic sprout and see if these forces correlate with proliferation or
gene expression patterns.
5.2.2 Further understanding the mechanism behind adhesion regulation of
angiogenesis
While our studies revealed a role for Pyk2 in regulating angiogenesis promoted by
limited adhesion, several questions still remain. Does Pyk2 have a similar role in vivo?
While Pyk2-knockout mice are viable (Okigaki et al., 2003), previous studies
demonstrated impaired revascularization of ischemic hindlimbs in Pyk2-knockout adult
mice (Matsui et al., 2007), consistent with the limited expression of Pyk2 in embryonic
endothelium (Avraham et al., 1995; Sasaki et al., 1995). We are planning to investigate
the ability of Pyk2-knockout endothelial cells to vascularize less versus highly adhesive
materials using subcutaneous implants and the ex vivo aortic ring sprouting assay. Given
our hypothesis that Pyk2 regulates angiogenesis in limited adhesive contexts while FAK
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regulates angiogenesis in highly adhesive contexts, it would be interesting to carry out the
same experiments with FAK-knockout mice.
Our results also suggested that Pyk2 and FAK might be responsible for regulating
different cell types in angiogenic sprouts. While inhibition of Pyk2, but not FAK,
decreased sprouting from spheroids of pure endothelial cells, they appeared to regulate
sprouting synergistically from aortic arch explants containing both endothelial cells and
supporting mesenchymal cells. This result raised the possibility that Pyk2 is acting
primarily in endothelial cells, while FAK is regulating the behavior of mesenchymal
cells. It would be interesting to look at Pyk2 and FAK activity in the two cell populations
in sprouts, as well as to manipulate Pyk2 in endothelial cells and FAK in mesenchymal
cells before mixing together into spheroids to observe sprouting.
Upstream of Pyk2 and FAK signaling, it would be informative to know whether
certain integrin subtypes—in addition to overall levels of adhesion—are responsible for
activating Pyk2 versus FAK and subsequent downstream functions. FAK has been
shown to couple to integrin αvβ5 in response to VEGF to promote angiogenesis (Eliceiri
et al., 2002). Indirectly, we have observed increased gene expression in cells cultured on
low versus high densities of several ECM proteins—fibronectin, vitronectin, and
laminin—and did not observe a significant effect on gene expression with knockdown of
various integrin subunits (not shown). These data suggest that Pyk2-mediated gene
expression may be responsive to overall levels of adhesion but not necessarily to specific
integrin signaling, although more direct experiments—such as examining whether Pyk2
couples to specific integrins in response to VEGF or looking at Pyk2 and FAK activity in
response to function blocking or knockdown of specific integrins—would be useful.
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Further downstream, we have identified a set of transcription factors that could be
responsible for the differences in gene expression observed between more and less
adherent cells. Additional studies are needed to determine if specific transcription factors
are master regulators of large sets of adhesion-responsive genes in endothelial cells and
whether these factors are controlled by Pyk2 signaling.
5.2.3 Role of multicellular interactions in ECM regulation of angiogenesis
While several studies have now investigated ECM regulation of both single
endothelial cell behavior and complex multicellular sprouting, we still do not understand
how endothelial cell interactions with other endothelial cells and supporting
mesenchymal cells affect this regulation. It is known that cell-cell contact affects cellECM interactions (Adams et al., 1998, Zhu, 1996 #197, Levenberg, 1998 #198;
Levenberg et al., 1998; Zhu and Watt, 1996) and vice versa (Wang et al., 2006). In our
studies, while we observed increased gene expression in single endothelial cells cultured
in limited adhesive contexts, this response was inhibited in confluent endothelial cells of
similar spread areas. This result could potentially correlate with quiescent cells in a
vascular monolayer, as opposed to actively sprouting endothelial cells that have lost
many of their cell-cell contacts. It would be interesting to look at gene expression
patterns in quiescent and actively angiogenic vessels in situ to see any differences in
confluent versus sprouting endothelial cells, as well as in confluent regions with VEcadherin contacts disrupted. Work from our lab has also demonstrated a requirement for
cell-cell contact for endothelial cells to proliferate in response to mechanical stretch (Liu
et al., 2007). These results, along with work demonstrating increased proliferation of
endothelial monolayers at regions of higher stress (Nelson et al., 2005), provide one
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potential explanation for increased proliferation of stalk cells in angiogenic sprouts
(Gerhardt et al., 2003), with migrating tip cells pulling and propagating stress toward
stalk cells at the base of the sprouts.
In addition to homotypic endothelial cell-cell interactions, it will be essential to
understand the role of supporting mesenchymal cells—in particular pericytes and smooth
muscle cells—in controlling angiogenic response to changes in ECM properties. While it
is traditionally thought that endothelial tip cells are the first to sprout and interact with a
new matrix, could it be possible that pericytes first sprout and provide a path for
endothelial cells to follow? This possibility is substantiated by the empty basement
membrane “sleeves” and accompanying pericytes left behind after vessels regressed in
response to inhibition of VEGF receptor—which quickly promoted revascularization
upon withdrawal of the drug (Mancuso et al., 2006). If pericytes are indeed early tip cells
and depositers of new matrix, it will be important to study how ECM properties regulate
both pericyte and endothelial cell behavior, as well as how much endothelial cells are
interacting with pericyte-deposited matrix as opposed to the initial matrix present. Our
lab has recently obtained mice in which both endothelial and pericyte/smooth muscle
cells are labeled, which should greatly enable studies to probe these questions.

5.3 Remaining engineering challenges and potential solutions
5.3.1 Optimizing design and control of synthetic materials
Toward our goal of developing tunable synthetic materials for tissue
vascularization, significant progress has been made with the development of PEG
hydrogels that are mechanically tunable and can be functionalized in a modular fashion
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with adhesive, degradable, and pro-angiogenic factor-presenting properties.
challenges still remain, though.

Several

While these materials allow for more independent

control of parameters than native ECM matrices, there is still some coupling between
parameters, for example differences in the ability of MMPs to access and degrade
hydrogels with changes in weight percent to vary mechanical properties, or our
observation that lower concentrations of adhesive peptide (with constant concentration of
total mono-acrylated peptide) may render gels more degradable. While it is unlikely that
we can decouple parameters completely, we can nonetheless try to compensate for
accompanying parameter shifts using our materials toolbox.

For instance, less

degradable peptide sequences can be used in lower weight percent or lower adhesive
peptide materials such that degradability is not affected by changes in mechanical
stiffness or adhesive ligand density. While this precise control is useful for mechanistic
studies of angiogenesis, it may ultimately not be so necessary for applications in
vascularizing implanted engineered tissues. Indeed, we only need to be able to achieve
the desired degree and timing of vascularization and to ensure any other encapsulated
cells are well supported by the material.
An additional challenge is the incorporation, retention, and appropriate release of
growth factors from synthetic materials. These materials do not possess growth factor
binding sites as many native ECMs do, and thus retention and in vivo-like presentation of
growth factors is difficult to achieve. For angiogenesis in particular, growth factors need
to be released to attract vessel ingrowth but also retained in the material for appropriate
network formation. Several advances have been made in this area, however, including
the covalent binding of VEGF that can be subsequently released by proteolytic
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degradation as cells migrate through the material (Zisch et al., 2003), as well as the
covalent incorporation of heparin as a way to sequester endogenously present growth
factors that closely recapitulates how native materials retain growth factors (SakiyamaElbert and Hubbell, 2000). Indeed, it will likely be beneficial to incorporate more
biomimetic components to take advantage of both the control afforded by synthetic
approaches and the established efficacy of natural principles. A recent example employs
factor XIII—which crosslinks fibrin gels—as a means to crosslink synthetic materials
(Ehrbar et al., 2007).
5.3.2 Engineering an angiogenic sprout
To test our hypothesis that adhesive and mechanical gradients along an
angiogenic sprout are in part responsible for the different phenotypes observed, it would
be useful to engineer a system that recapitulated elements of a sprouting vessel. For
example, one could start with a channel through an ECM material lined with endothelial
cells, similar to the model developed by Tien and colleagues (Chrobak et al., 2006).
Using a synthetic material that can be patterned with gradients or alternating lines of
adhesive ligand or varying mechanical properties, we could test whether regions of
higher adhesive ligand density or mechanical stiffness promoted proliferation, or whether
regions of lower ECM density promoted an invasive phenotype and were locations of
new sprouting off the existing channel.

The engineered vessel could also be

mechanically stretched, similar to an approach by Mooney and colleagues (Matsumoto et
al., 2007), to assess whether regions of higher strain—potentially similar to strains
experienced by stalk cells—promote proliferation, or whether these strains dictate the
location of neovessel sprouting.
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5.4 Concluding Remarks
Multiple properties of the ECM—from mechanical stiffness to presentation of
adhesive ligands—are crucial regulators of angiogenesis. While the effects of integrinmediated adhesion, cell spreading, and matrix stiffness are being explored, many basic
questions remain: how do these properties interact in regulating angiogenesis? Is there
an “optimal” angiogenic response or are there merely variations in the quality of
angiogenesis, and can these responses be traced directly back to specific signaling
pathways responsive to changes in cell-ECM interaction?

In order to answer such

questions, knowledge and expertise in materials engineering and biology need to be
tightly coupled.

To engineer materials that optimize vascular ingrowth to support

implanted tissues, we need to take advantage of our basic knowledge of how ECM ligand
presentation, stiffness, and degradation, as well as soluble factor cues and cell-cell
interactions, regulate angiogenesis. Similarly, we can utilize tools available to control
material properties and cellular interactions precisely and systematically to further our
understanding of the basic processes of angiogenesis. This thesis has aimed to integrate
biology and engineering by using microfabrication and synthetic materials tools to study
ECM regulation of angiogenesis in a more controlled manner, as well as utilizing basic
biological knowledge to design materials for therapeutic angiogenesis and tissue
engineering.
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